<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Rev Endocr Metab Disord</journal-id>
<journal-id journal-id-type="iso-abbrev">Rev Endocr Metab Disord</journal-id>
<journal-title-group>
<journal-title>Reviews in Endocrine &amp; Metabolic Disorders</journal-title>
</journal-title-group>
<issn pub-type="ppub">1389-9155</issn>
<issn pub-type="epub">1573-2606</issn>
<publisher>
<publisher-name>Springer US</publisher-name>
<publisher-loc>New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30198059</article-id>
<article-id pub-id-type="pmc">6208575</article-id>
<article-id pub-id-type="publisher-id">9455</article-id>
<article-id pub-id-type="doi">10.1007/s11154-018-9455-2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Impact of pregnancy on inborn errors of metabolism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8953-2403</contrib-id>
<name>
<surname>Wilcox</surname>
<given-names>Gisela</given-names>
</name>
<address>
<phone>+44 (0)161 206 4365</phone>
<email>Gisela.Wilcox@manchester.ac.uk</email>
<email>Gisela.Wilcox@srft.nhs.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121662407</institution-id><institution-id institution-id-type="GRID">grid.5379.8</institution-id><institution>School of Medical Sciences, Faculty of Biology Medicine &amp; Health, </institution><institution>University of Manchester, </institution></institution-wrap>Manchester, UK </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0237 2025</institution-id><institution-id institution-id-type="GRID">grid.412346.6</institution-id><institution>The Mark Holland Metabolic Unit, </institution><institution>Salford Royal Foundation NHS Trust, </institution></institution-wrap>Salford, Greater Manchester, M6 8HD UK </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>10</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>10</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2018</year>
</pub-date>
<volume>19</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>33</lpage>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Once based mainly in paediatrics, inborn errors of metabolism (IEM), or inherited metabolic disorders (IMD) represent a growing adult medicine specialty. Individually rare these conditions have currently, a collective estimated prevalence of &gt;1:800. Diagnosis has improved through expanded newborn screening programs, identification of potentially affected family members and greater awareness of symptomatic presentations in adolescence and in adulthood. Better survival and reduced mortality from previously lethal and debilitating conditions means greater numbers transition to adulthood. Pregnancy, once contraindicated for many, may represent a challenging but successful outcome. Successful pregnancies are now reported in a wide range of IEM. Significant challenges remain, given the biological stresses of pregnancy, parturition and the puerperium. Known diagnoses allow preventive and pre-emptive management. Unrecognized metabolic disorders especially, remain a preventable cause of maternal and neonatal mortality and morbidity. Increased awareness of these conditions amongst all clinicians is essential to expedite diagnosis and manage appropriately. This review aims to describe normal adaptations to pregnancy and discuss how various types of IEM may be affected. Relevant translational research and clinical experience will be reviewed with practical management aspects cited. Based on current literature, the impact of maternal IEM on mother and/or foetus, as well as how foetal IEM may affect the mother, will be considered. Insights gained from these rare disorders to more common conditions will be explored. Gaps in the literature, unanswered questions and steps to enhance further knowledge and systematically capture experience, such as establishment of an IEM-pregnancy registry, will be summarized.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Pregnancy</kwd>
<kwd>Inborn errors of metabolism</kwd>
<kwd>Metabolic disorders</kwd>
<kwd>Mitochondrial</kwd>
<kwd>Urea cycle</kwd>
<kwd>Fatty acid oxidation</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>University of Manchester</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Science+Business Media, LLC, part of Springer Nature 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p id="Par2">
<disp-quote><p id="Par3">
<italic>Dedicated to my mother Patricia Lorraine (Young) Wilcox 1928 – 2017 who taught me my first lesson in Rare Diseases: "Is it rare? Or is it just rarely diagnosed?"</italic>
</p></disp-quote>
</p>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par4">Once mainly in the domain of paediatrics, inborn errors of metabolism (IEM), or inherited metabolic disorders (IMD) the preferred term in clinical practice, represent a growing specialty in adult medicine [<xref ref-type="bibr" rid="CR1">1</xref>]. Reasons for this include improved diagnosis through expanded newborn screening programs, identification of potentially affected family members and greater awareness of symptomatic presentations in adolescence and in adulthood. Greatly improved survival and reduced mortality from previously lethal and debilitating conditions have enabled survival into adulthood and greater participation in society [<xref ref-type="bibr" rid="CR2">2</xref>]. Sigmund Freud described the stage of adulthood as being ‘to love and to work’ [<xref ref-type="bibr" rid="CR3">3</xref>]. Pregnancy in women with IEM can be seen, as a successful outcome of survival and transition into adulthood, achieving as normal a life as possible.</p>
<p id="Par5">Once thought to be contraindicated for many conditions, there are now accumulating reports of successful pregnancies in a wide range of IEM [<xref ref-type="bibr" rid="CR4">4</xref>]. There do remain significant challenges however, given the biological stresses of pregnancy, parturition and the puerperium. Outcomes are most favourable where the diagnosis of an IEM is known, allowing preventive and pre-emptive management. Unrecognized metabolic disorders have been, and remain, a preventable cause of maternal and neonatal mortality and morbidity. Increased awareness of these conditions amongst all clinicians is essential to expedite diagnosis and manage appropriately. Helpful and detailed recent reviews have been published on the clinical experience [<xref ref-type="bibr" rid="CR4">4</xref>] including practical management of such pregnancies [<xref ref-type="bibr" rid="CR5">5</xref>]. Improved understanding may enable anticipation of possible problems especially where current knowledge and experience is limited and thinking from first principles may be required.</p>
<p id="Par6">The focus of this review is to describe normal adaptations to pregnancy, discuss how various types of IEM may be affected in this setting and integrate current experience of such pregnancies in the literature. Where relevant, insights gained from these rare IEM to more common conditions will be explored.</p>
<p id="Par7">Finally, gaps in the literature, unanswered questions and steps to enhance further knowledge and experience will be summarized.</p>
</sec>
<sec id="Sec2">
<title>Biological adaptations to pregnancy</title>
<p id="Par8">To understand the potential impact pregnancy may have in women with IEM we must first consider general adaptations to pregnancy. Anatomical and systemic physiological changes, from conception to the puerperium, are, necessarily effected by modification of subcellular metabolism under genomic and endocrine influence.</p>
<p id="Par9">We will therefore discuss in turn, anatomical and body composition changes from conception to the post-partum period, physiological and metabolic adaptations to pregnancy.</p>
<sec id="Sec3">
<title>Anatomical changes</title>
<p id="Par10">Over the 40 gestational weeks of pregnancy through the post-partum period there are substantial changes, beyond foetal development, in maternal body composition [<xref ref-type="bibr" rid="CR6">6</xref>] Fig. <xref ref-type="fig" rid="Fig1">1</xref>a and b). Current knowledge of body composition in pregnancy, as well as relevant methodology, has been reviewed [<xref ref-type="bibr" rid="CR6">6</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p><bold>a Foeto-placental growth across pregnancy.</bold> Adapted from King JC, Reference [<xref ref-type="bibr" rid="CR7">7</xref>]: Physiology of pregnancy and nutrient metabolism. Am J Clin Nutr. 2000;71(5 Suppl):1218s–25s. <bold>b Maternal body composition changes across pregnancy and the puerperium.</bold> Adapted from <italic>Kopp-Hoolihan</italic> et al in Reference [<xref ref-type="bibr" rid="CR6">6</xref>]: Widen EM, Gallagher D. Body composition changes in pregnancy: measurement, predictors and outcomes. Eur J Clin Nutr. 2014;68(6):643–52. <bold>c Protein requirements in pregnancy by method.</bold> Recent methodology by <italic>in vivo</italic> amino acid oxidation (IAAO) suggests protein requirements, whether by Estimated Average Requirement (50th percentile) or Recommended Daily Allowance (97th percentile) are significantly higher than previous estimates. Source: adapted from content in (reference [<xref ref-type="bibr" rid="CR8">8</xref>]): Elango R, Ball RO. Protein and Amino Acid Requirements during Pregnancy. Adv Nutr. 2016;7(4):839s44s. <ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/advances/article/7/4/839S/4568693">https://academic.oup.com/advances/article/7/4/839S/4568693</ext-link></p></caption><graphic id="MO1" xlink:href="11154_2018_9455_Fig1_HTML"></graphic></fig></p>
<p id="Par11">These changes are reflected in the requirements for protein and its component amino acids, essential fatty acids, calcium, iron and other key micronutrients, with energy storage and utilization during pregnancy being derived from carbohydrate (glucose) and lipids [<xref ref-type="bibr" rid="CR7">7</xref>] <italic>(see section</italic>
<xref ref-type="sec" rid="Sec5"><italic>2.3</italic></xref><italic>).</italic></p>
</sec>
<sec id="Sec4">
<title>Physiological adaptations</title>
<p id="Par12">Alterations in total body water and its compartments contribute to cardiovascular changes observed during pregnancy [<xref ref-type="bibr" rid="CR9">9</xref>]. Increased plasma volume, hence venous return, affects preload. Systemic vascular resistance, reduced via oestrogen and nitric oxide mediated vasodilatation, decreases afterload. S<italic>troke volume</italic>, the blood volume pumped into the systemic circulation per cardiac cycle, increases by 20–30%. Maternal heart rate increases from the first to the third trimester. Therefore, cardiac output increases by 30–50% during a singleton pregnancy. This supports uterine and placental blood flow, accounting for around 25% of the total. Increased renal, mammary and skin blood flow support the increased oxygen requirements of these maternal organs [<xref ref-type="bibr" rid="CR9">9</xref>]. The substantially increased metabolic demands during pregnancy are discussed in section <xref ref-type="sec" rid="Sec5">2.3</xref>.</p>
<p id="Par13">Respiratory physiological changes include tidal volume increasing by 30–50%, respiratory rate rising by 1–2 breaths/min and development of a mild respiratory alkalosis. Oxygen consumption increases by 30%, with maternal metabolic rate increasing by 15% [<xref ref-type="bibr" rid="CR9">9</xref>]. Systemic and renal vasodilatation increase renal blood flow. Glomerular filtration rate increases 40–50% by the end of the first trimester with creatinine clearance increasing correspondingly. This contributes to altered renal threshold for glucose reabsorption. Glomerular membrane charge selectivity alters, which together with raised GFR, increases urinary albumin and protein excretion [<xref ref-type="bibr" rid="CR9">9</xref>]. Changes in maternal bone and mineral metabolism occur during pregnancy and post-partum. The foetus accretes 30 g calcium, 20 g phosphorus and 0.8 g magnesium by end gestation. This was recently reviewed [<xref ref-type="bibr" rid="CR10">10</xref>]. Altered gut motility with reduced lower oesophageal sphincter tone, delayed gastric emptying and slowed intestinal transit time are well described, attributed largely to progesterone [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
<p id="Par14">Normal liver function includes synthetic, excretory and metabolic functions. Synthesis of proteins includes clotting proteins, lipids and transport proteins like albumin. Excretory functions encompass catabolism and excretion of bile acids, detoxification and biotransformation of xenobiotics and hormones. As the sentinel organ of intermediary metabolism, metabolic functions include nitrogen metabolism, transamination and ureagenesis; regulation of carbohydrate metabolism includes galactose metabolism, glycolysis, glycogenolysis and glycogen storage, as well as lipid synthesis, storage and metabolism [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
<p id="Par15">Pregnancy significantly influences liver function. Synthesis of proteins, such as lipoproteins and coagulation factors, increase under hormonal influence [<xref ref-type="bibr" rid="CR9">9</xref>]. A hypercoagulable state results, particularly relevant in homocystinuria where thrombosis risk is already increased [<xref ref-type="bibr" rid="CR5">5</xref>]. Effects on intermediary metabolism are discussed further below.</p>
</sec>
<sec id="Sec5">
<title>Metabolic adaptations to the demands of pregnancy</title>
<sec id="Sec6">
<title>Energy balance and calorie requirements in pregnancy</title>
<p id="Par16">The energy required to support the metabolic demands of an average full-term singleton pregnancy is approximately 38,000 Kcal with the major energy cost coming near term with estimated BMR increase of around 230 Kcal per day [<xref ref-type="bibr" rid="CR7">7</xref>].</p>
<p id="Par17">In the first two trimesters of pregnancy, maternal anabolism predominates, with enhanced insulin sensitivity. Where food availability permits, maternal fat- and fat-free mass increase over this period [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. From around 30 weeks’ gestation, placental hormones and adipocytokines drive increasing insulin resistance [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], favouring maternal catabolism, liberating glucose, amino acids and lipids to support exponential foetal growth. Maternal catabolism may be exaggerated in the third trimester where nutritional state is borderline [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
</sec>
<sec id="Sec7">
<title>Carbohydrate metabolism</title>
<p id="Par18">Lipolysis-derived glycerol becomes a preferred substrate for maternal gluconeogenesis [<xref ref-type="bibr" rid="CR14">14</xref>] while maternal glucose is diverted for foetal consumption. In late pregnancy, around 50% of maternal glucose production is utilized by the foetus. Fasting maternal glucose levels are reduced throughout pregnancy reflecting enhanced hepatic and placental uptake. In later pregnancy peripheral (muscle) insulin resistance is associated with higher postprandial glucose levels. Glucose passes across the placenta via GLUT1 facilitated diffusion, down a concentration gradient [<xref ref-type="bibr" rid="CR13">13</xref>]. These processes are reviewed in greater depth in recent reviews of metabolism in gestational diabetes [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
</sec>
<sec id="Sec8">
<title>Amino acid metabolism</title>
<p id="Par19">Amino acids are actively and differentially transported across the placenta [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>] supporting foetal growth, while maternal plasma amino acid levels are progressively lowered [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR17">17</xref>] Fig. <xref ref-type="fig" rid="Fig2">2</xref>. These changes are evidenced by recent metabolomic studies [<xref ref-type="bibr" rid="CR18">18</xref>]. The differential between maternal and foetal plasma amino acid levels varies between individual amino acids and across trimesters. This has implications for inherited inborn errors of protein metabolism, such as phenylketonuria, in pregnancy, where foetal uptake is greater relative to some other amino acids.<fig id="Fig2"><label>Fig. 2</label><caption><p><bold>Amino acid concentrations across pregnancy trimesters.</bold> Barplot comparing plasma amino acid concentrations across trimesters among pregnant women. Median (+ Interquartile range/2) was plotted. * <italic>p</italic>-value &lt;0.00017, p-value was calculated by Mann-Whitney U Test between trimesters. Source: (Reference [<xref ref-type="bibr" rid="CR17">17</xref>]) Lindsay KL, Hellmuth C, Uhl O, Buss C, Wadhwa PD, Koletzko B, et al. Longitudinal Metabolomic Profiling of Amino Acids and Lipids across Healthy Pregnancy. PLoS One. 2015;10(12):e0145794</p></caption><graphic id="MO2" xlink:href="11154_2018_9455_Fig2_HTML"></graphic></fig></p>
<p id="Par20">Protein requirements are increased from early pregnancy and increase throughout gestation [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Contemporary methods such as <italic>in vivo</italic> amino acid oxidation suggest previous estimates of gestational protein requirements, based historically from extrapolation of nitrogen balance studies in men, may be insufficient, especially in late pregnancy, Fig. <xref ref-type="fig" rid="Fig1">1</xref>c [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
</sec>
<sec id="Sec9">
<title>Lipid metabolism</title>
<p id="Par21">Maternal plasma VLDL cholesterol and triglycerides increase during pregnancy, with oestrogen-mediated decreased hepatic lipoprotein lipase [<xref ref-type="bibr" rid="CR20">20</xref>]. HDL and LDL are additionally triglyceride enriched via cholesterol ester transport protein (CETP). [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Placental hormone-sensitive lipase releases free fatty acids, including long chain essential fatty acids, to support foetal growth and development. Long chain fatty acids (LCFA) are transported across the plasma membrane via the LCFA transporter, then esterified and bound to fatty acid binding proteins (FABP). Carnitine, via the plasma membrane carnitine transporter, enters the cytoplasm and combines with the LCFA esters, and is itself transported across the inner and outer mitochondrial membranes by Carnitine Palmitoyl Transporters (CPT) 1 and 2 respectively. Medium chain (MCFA) and short chain fatty acids (SCFA) can enter the cell and into the mitochondria independently of carnitine and its transporters [<xref ref-type="bibr" rid="CR21">21</xref>].</p>
<p id="Par22">Human placental tissue is mitochondrial-rich [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] and generates ATP from beta oxidation of very long chain fatty acids (VLFA), cleaving them into shorter subunits, as well as utilizing medium chain fatty acids (MCFA) and short chain fatty acids (SCFA) for ATP synthesis, [<xref ref-type="bibr" rid="CR24">24</xref>]. Peroxisomal functions are complex, include elongation of EPA to DHA, apparently enhanced in the foeto-placental unit, as well as metabolism of more complex lipids e.g. phytanic acid a branched long chain fatty acid of ruminant origin [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR27">27</xref>].</p>
<p id="Par23">Ketones generated from mitochondrial fatty acid oxidation are used as a maternal fasting energy supply, as well as for foetal energy and brain development [<xref ref-type="bibr" rid="CR13">13</xref>]. Cholesterol is essential for foetal development and metabolism. There is evidence for both de-novo foetal synthesis as well as placental transport of maternal cholesterol [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
<p id="Par24">The importance of lipid metabolism in human, as opposed to rat, pregnancy is now much better recognized. One can speculate on the significant interspecies differences in relative brain size and development [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
<p id="Par25">The clinical importance of lipid metabolism in normal pregnancy is highlighted by the complex foeto-maternal pathology that occurs in pregnancies where there are inborn errors of lipid metabolism, in the mother and/or foetus [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
</sec>
</sec>
<sec id="Sec10">
<title>Parturition</title>
<p id="Par26">The physiology of labour is complex and has recently been reviewed from the perspective of myometrial function [<xref ref-type="bibr" rid="CR30">30</xref>]. From a metabolic standpoint it represents prolonged and intense muscular activity where the energy requirements are substantial [<xref ref-type="bibr" rid="CR30">30</xref>]. Whether altered cellular metabolism e.g. acidosis in specific IEM influences myometrial function in labour has not been directly studied.</p>
</sec>
<sec id="Sec11">
<title>Post-partum</title>
<p id="Par27">Following delivery of the foetus and placenta, maternal endocrine and metabolic status changes abruptly, while the newborn rapidly adjusts to post-uterine life. Maternal catabolism is pronounced with energy and nutrients being diverted to milk production from the third postpartum day. Uterine involution is especially rapid in the first 10–14 days post-partum; by six weeks post-partum it has returned to pre-pregnancy size. This mobilizes amino acids for lactation. The abrupt post-partum oestrogen decline similarly facilitates maternal skeletal calcium mobilization [<xref ref-type="bibr" rid="CR10">10</xref>] Post-partum maternal body composition changes resulting from catabolism are evident in Fig. <xref ref-type="fig" rid="Fig1">1</xref>b.</p>
<p id="Par28">This is a therefore a period of exceptionally high risk for decompensation of inborn metabolic disorders in at risk-mothers and neonates. Many such disorders present for the first time in the post-partum or neonatally.</p>
<p id="Par29">In this section of the article we have reviewed the anatomical, physiological and metabolic adaptations that occur in normal pregnancy and puerperium as a framework to review what happens when an IEM is present in the mother and/or in specific situations, the foetus.</p>
</sec>
</sec>
<sec id="Sec12">
<title>Types of IEM and how they may be impacted upon by pregnancy</title>
<p id="Par30">IEM represent numerous individually rare conditions with current collective prevalence of &gt;1:800 [<xref ref-type="bibr" rid="CR31">31</xref>]. They can be variously classified. As broad categories they encompass respectively, disorders of intermediary metabolism, mitochondrial energy metabolism and organelle-based disorders such lysosomal storage disorders [<xref ref-type="bibr" rid="CR32">32</xref>]. Effects of pregnancy may differ between these groups which will therefore be discussed separately, with emphasis on disorders of intermediary and of mitochondrial energy metabolism.</p>
<p id="Par31">In exploring the types of impact pregnancy may have on IEM, insights from translational research and clinical experience will be reviewed. Where relevant this will include effects of pregnancy on maternal IEM, maternal IEM on the foetus and/or foetal IEM on maternal pathophysiology.</p>
<p id="Par32">These first two categories are exemplified by well described inborn errors of protein and amino acid metabolism.</p>
<sec id="Sec13">
<title>IEM of intermediary metabolism</title>
<sec id="Sec14">
<title>Inborn errors of protein and amino acid metabolism</title>
<sec id="FPar1">
<title>Urea cycle disorders</title>
<p id="Par33">The urea cycle, first described by Hans Krebs in 1932, is a series of 6 enzymes located in the liver. Its major role is to convert ammonia generated from excess protein intake or catabolism into urea. The urea cycle also regulates acid-base balance, consuming bicarbonate, and generates the amino acids citrulline, arginine and ornithine. Urea cycle dysfunction may occur where activity of any of the six enzymes, or their required transporters, co-factors or energy (as ATP) is lacking. The first three urea cycle enzymes are intra-mitochondrial while the remaining enzymes are cytosolic, Fig. <xref ref-type="fig" rid="Fig3">3</xref>a [<xref ref-type="bibr" rid="CR34">34</xref>].<fig id="Fig3"><label>Fig. 3</label><caption><p><bold>a The urea cycle.</bold> In hepatocytes, the rate-limiting, ATP-dependent enzyme carbamoyl phosphate synthetase 1 (CPS1), which is allosterically activated by N-acetyl glutamate (NAG), produced by N-acetyl glutamate synthase (NAGS), <italic>not shown</italic>, and ornithine transcarbamylase (OTC) are located in the mitochondria; argininosuccinate synthetase (ASS), argininosuccinate lyase (ASL) and arginase (ARG) are in the cytoplasm. Inherited defects in any of these enzymes can cause recurrent episodes of hyperammonemia. Defects in two mitochondrial transporters, <italic>not shown</italic>, may also result in hyperammonemia. Source: Adapted from reference [<xref ref-type="bibr" rid="CR33">33</xref>]: Laemmle A, Gallagher RC, Keogh A, Stricker T, Gautschi M, Nuoffer JM, et al. Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD). PLoS One. 2016;11(4):e0153358. <bold>b Post-partum course of term OTC pregnancy.</bold> Complicated post-partum course in a female with OTC due to partial X chromosome deletion. Abbreviations: CHO – carbohydrate; CS – Caesarian Section; NH<sub>4</sub> – ammonia; OTC - ornithine transcarbamylase; IV – intravenous. Source: Goldstein R, Smith N, Strauss BJG &amp; Wilcox G. Protein aversion and disordered eating in OTC deficiency: a challenge for pregnancy and post-partum management in a female heterozygote. 25th DMIMD, London, UK April 2011</p></caption><graphic id="MO3" xlink:href="11154_2018_9455_Fig3_HTML"></graphic></fig></p>
<p id="Par34">Inheritance of ornithine transcarbamylase (OTC) is X-linked, with more variable phenotypic expression in ‘carrier’ females; the remaining enzymes are autosomal recessive. Deficiencies of any of these enzymes may be associated with hyperammonaemia, [<xref ref-type="bibr" rid="CR32">32</xref>] though is less frequent in arginase deficiency [<xref ref-type="bibr" rid="CR35">35</xref>].</p>
<p id="Par35"><italic>Toxic effects of ammonia on the brain</italic> have been well described [<xref ref-type="bibr" rid="CR36">36</xref>] and may manifest clinically as neuro-psychiatric symptoms such as agitation, mood swings, perseveration, delirium, hallucinations, seizures, ataxia, psychomotor retardation and fluctuating conscious state as well as coma. Sodium valproate, though contraindicated in pregnancy, is well known to unmask inherited UCD due to its inhibition of urea cycle enzymes [<xref ref-type="bibr" rid="CR37">37</xref>] It is important to note that adults with genetic causes of hyperammonaemia tolerate lower plasma levels than those commonly seen in chronic liver disease and are less tolerant than neonates and children with IEM [<xref ref-type="bibr" rid="CR36">36</xref>].</p>
<p id="Par36"><italic>Gastrointestinal symptoms</italic> of UCD may include aversion to dietary protein, anorexia, nausea, cyclical eating patterns, and acute liver failure (ALF) associated with hyperammonaemia, recently reviewed by Bigot [<xref ref-type="bibr" rid="CR33">33</xref>]. Beyond paediatric presentations, Laemmle et al. reported ALF in 40% of confirmed OTC symptomatic females, including adults [<xref ref-type="bibr" rid="CR38">38</xref>]. Ammonia-induced suppression of hepatic protein synthesis, mitochondrial dysfunction, damage and cell death appear to be the mechanisms involved, based on various lines of evidence, including liver biopsy [<xref ref-type="bibr" rid="CR38">38</xref>]. The late rise in transaminases relative to ammonia elevation is a clue to the aetiology. Intramitochondrial UCD may be more prone to ALF and energy deficit may add to mitochondrial compromise. <italic>Importantly, the liver failure is reversible with timely and appropriate treatment of hyperammonaemia, avoiding the need for liver transplantation.</italic></p>
<p id="Par37"><italic>Triggers for acute metabolic decompensation</italic> are typically excess exogenous protein load and/or the presence of catabolic stressors such as infection, surgery, glucocorticoid therapy and inadequate caloric intake. Prevention is by maintaining a protein intake closely matched to requirements to minimize protein catabolism, and, ensuring adequate intake of non-protein calories. Ammonia scavenging medications enhance nitrogen excretion via alternative pathways and may be used preventively as well as during acute decompensations. A sick-day regimen, with ample non-protein calories to meet daily energy requirements is used during intercurrent illness to minimize catabolism. Intravenous glucose (and/or lipid) and hospitalization may be needed if enteral administration is not possible. Management of metabolic decompensation requires monitoring of ammonia, plasma amino acids, acid base, routine bloods and neurological observations, as well investigation for the underlying cause and any potential complications. It should be noted that clinical status can change dramatically within a few hours. In severe hyperammonaemia, haemofiltration may be needed. For further details, see references [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR39">39</xref>].</p>
</sec>
<sec id="FPar2">
<title>Urea cycle disorders in pregnancy</title>
<p id="Par38">In the face of increased metabolic demands, and requirements for protein, amino acids and energy there is a risk of decompensation where these are not met and/or catabolism is excessive overwhelming already limited capacity for ureagenesis and ammonia consumption.</p>
<p id="Par39">Decompensation is riskiest where the diagnosis is unrecognized and/or treatment is delayed or not given. Conversely, better outcomes are observed where the UCD (and pregnancy) diagnosis is known.</p>
<p id="Par40">In 1990 a seminal New England Journal of Medicine case series [<xref ref-type="bibr" rid="CR40">40</xref>], reported post-partum coma and death in previously undiagnosed OTC-deficient female carriers. Subsequent numerous publications described various pregnancy outcomes in OTC [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR55">55</xref>] and other urea cycle disorders: citrullinaemia type 1 [<xref ref-type="bibr" rid="CR56">56</xref>–<xref ref-type="bibr" rid="CR61">61</xref>], ASA/ASL deficiency [<xref ref-type="bibr" rid="CR62">62</xref>–<xref ref-type="bibr" rid="CR64">64</xref>], CPS deficiency [<xref ref-type="bibr" rid="CR65">65</xref>] and lysinuric protein intolerance [<xref ref-type="bibr" rid="CR66">66</xref>–<xref ref-type="bibr" rid="CR68">68</xref>]. Currently, no reports of pregnancy outcome in either NAGS deficiency, Arginase deficiency, Citrin deficiency (citrullinaemia type 2) or Hyperornithinaemia-Hyperammonaemia-Homocitrullinaemia (HHH) syndrome are published.</p>
<p id="Par41"><italic>Adverse pregnancy outcomes reported have been principally neurological, psychiatric or hepatic.</italic> The importance of acute hepatic failure as a manifestation of metabolic decompensation has been not been fully appreciated until recently [<xref ref-type="bibr" rid="CR38">38</xref>]. Such presentations, occurring at any stage in pregnancy, may have gone undiagnosed. Whether they are represented in referrals to liver transplant units is worthy of investigation. Mitochondrial dysfunction [<xref ref-type="bibr" rid="CR69">69</xref>] and liver disease will be discussed further with fatty acid oxidation disorders in pregnancy.</p>
<p id="Par42"><italic>Complications of hyperammonaemia in pregnancy can masquerade as more common problems.</italic> Nausea, vomiting, headaches, mood disturbance and seizures may be attributed to hormonal changes. Mental status change post-partum has been diagnosed as post-partum psychosis or depression [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. Hyper-ammonaemic liver failure initially attributed to fatty liver of pregnancy, was considered unusual presenting in <italic>early</italic> pregnancy with hyperemesis, weight loss and prominent depression of synthetic function, [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. Hyperemesis gravidarum (HG) a risk factor for metabolic decompensation, due to caloric deficit, may be both a cause, and consequence, of hyperammonaemia. Late first trimester pregnancy weight loss from hyperemesis, malnutrition and institution of parenteral nutrition in an undiagnosed OTC heterozygote has caused fatal hyperammonaemic encephalopathy [<xref ref-type="bibr" rid="CR46">46</xref>]. Glucocorticoids recommended for HG [<xref ref-type="bibr" rid="CR72">72</xref>], an intercurrent condition [<xref ref-type="bibr" rid="CR56">56</xref>] or anticipated pre-term delivery [<xref ref-type="bibr" rid="CR42">42</xref>], may aggravate a catabolic state.</p>
<p id="Par43">
<italic>Understanding the metabolic adaptations to pregnancy provides a framework for understanding and anticipating the impact on an IEM.</italic>
</p>
<p id="Par44"><italic>Most reported complications occur in early pregnancy and post-partum.</italic> Progressive foetal and maternal second trimester anabolism generally confers greater metabolic stability. However, we have seen second trimester decompensation in OTC deficiency (G Wilcox unpublished observations), manifest by psychiatric disturbance, and responsive to intravenous arginine infusion; deficiency of this conditionally essential amino acid likely coincided with increased protein requirements.</p>
<p id="Par45">Third trimester protein tolerance is generally greater due to increasing protein requirements, but, failing adequate intake<xref ref-type="fn" rid="Fn1">1</xref> and/or catabolic stressors [<xref ref-type="bibr" rid="CR42">42</xref>] metabolic decompensation may occur. This is consistent with accelerated maternal catabolism in late pregnancy.</p>
<p id="Par47">Peripartum multidisciplinary planning in known patients includes clinical observation, ammonia monitoring and avoidance of prolonged fasting, using protein-free nutrition orally, or if necessary, parenterally.</p>
<p id="Par48"><italic>Most hyperammonaemic decompensations have been reported post-partum.</italic> Uterine involution takes 6 weeks but occurs rapidly in the first two weeks. The strength of catabolic drive from days 3–11 is such, that metabolic instability may still occur despite proactive appropriate management [<xref ref-type="bibr" rid="CR4">4</xref>] Table <xref ref-type="table" rid="Tab1">1</xref>. Additional catabolic stress may result from caesarian section, birth trauma, infection e.g. wound infection, mastitis (Fig. <xref ref-type="fig" rid="Fig3">3</xref>b). Blood transfusion may represent an added protein load. Breast feeding is possible so long as caloric intake is adequate. Table <xref ref-type="table" rid="Tab1">1</xref> summarizes largely previously unpublished experience from an historical case series.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Historical case series of pregnancies in women with urea cycle disorders</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Case</th><th>Age (years)</th><th>Diagnosis</th><th>Parity at delivery</th><th>Past pregnancy complications</th><th>Symptoms pre-pregnancy</th><th>Metabolic complications of pregnancy</th><th>Post-partum ammonia rise (<italic>N</italic> &lt; 50 μmol/l)</th><th>Nutritional deficiencies</th><th>Breast feeding</th></tr></thead><tbody><tr><td>1</td><td>40</td><td>OTC</td><td>2</td><td>‘Psychosis’ day 3 post-partum</td><td>Protein aversion</td><td>1° Trimester coma; Ammonia 288</td><td>117 day 5</td><td>–</td><td>Yes</td></tr><tr><td>2a<sup>a</sup></td><td>33</td><td>OTC</td><td>1</td><td>Elective termination for affected foetus</td><td>Protein aversion<break></break>decompensation</td><td>Post-partum<break></break>hyperammonaemia</td><td>226 day 4<break></break>246 day 8</td><td>zinc selenium<break></break>vitamin B12, iron<break></break>protein</td><td>Yes</td></tr><tr><td>2b</td><td>35</td><td>OTC</td><td>2</td><td>As above</td><td>Protein aversion decompensation</td><td>Post-partum &amp; 3° Trimester hyperammonaemia</td><td>105 day 2<break></break>150 day 4<break></break>125 day 9</td><td>zinc selenium<break></break>vitamin A<break></break>vitamin B12<break></break>protein<break></break>essential fatty acids</td><td>Yes</td></tr><tr><td>3a</td><td>32</td><td>OTC</td><td>3</td><td>No</td><td>Protein aversion</td><td>–</td><td>–</td><td>vitamin D, vitamin B12, iron magnesium</td><td>Yes</td></tr><tr><td>3b</td><td>35</td><td>OTC</td><td>4</td><td>As above</td><td>Protein aversion</td><td>Gestational diabetes</td><td>–</td><td>As above</td><td>Yes</td></tr><tr><td>4a</td><td>37</td><td>OTC</td><td>1</td><td>N/A</td><td>Protein aversion</td><td>Mild post-partum hyperammonaemia</td><td>105 day 3–4<break></break>107 day 9</td><td>vitamin D, vitamin B12 iron</td><td>Yes</td></tr><tr><td>4b</td><td>39</td><td>OTC</td><td>2</td><td>As above</td><td>Protein aversion</td><td>–</td><td>–</td><td>As above</td><td>Yes</td></tr><tr><td>5</td><td>25</td><td>OTC</td><td>1</td><td>N/A</td><td>Protein aversion anxiety depression</td><td>2° &amp; 3° Trimester altered mental status very low arginine normal ammonia</td><td>–</td><td>vitamin D<break></break>iron</td><td>Yes</td></tr><tr><td>6<sup>b,c</sup></td><td>19</td><td>Citrullinaemia</td><td>1</td><td>Past miscarriage</td><td>Nil</td><td>1–2° Trimester hyperemesis, ↓8Kg, weight loss, acute liver failure &amp; hyperammonaemia: NH3 165</td><td>–</td><td>vitamin D</td><td>Yes</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Goldstein R, Smith N, Strauss BJG &amp; Wilcox G. Protein aversion and disordered eating in OTC deficiency: a challenge for pregnancy and post-partum management in a female heterozygote. 11th DMIMD, London, UK April 2011</p><p><sup>b</sup>McCarthy EA Wilcox G, Paulsen G, Walker SP. Mid-trimester severe liver failure as an adult presentation of an inborn error of urea cycle metabolism. Royal Australian and New Zealand College of Obstetricians and Gynaecologists Annual Scientific Meeting, Sydney, September 2013</p><p><sup>c</sup>Reference number [<xref ref-type="bibr" rid="CR55">55</xref>]</p></table-wrap-foot></table-wrap></p>
<p id="Par49"><bold><italic>Phenylketonuria</italic></bold> (PKU) – <italic>an example where the main impact is on the developing foetus.</italic></p>
<p id="Par50">Phenylketonuria, is well known, with widespread neonatal screening pioneered by Robert Guthrie and others, since the 1960s [<xref ref-type="bibr" rid="CR73">73</xref>].</p>
<p id="Par51">PKU is due to absent or dysfunctional phenylalanine hydroxylase, which converts phenylalanine to tyrosine. Untreated, it leads to severe mental retardation and marked mood and behavioural disturbances [<xref ref-type="bibr" rid="CR73">73</xref>]. Excess phenylalanine is toxic to the developing brain and completes with other large neutral amino acids e.g. tryptophan crossing the blood brain barrier. Together with deficient tyrosine, this causes marked neurotransmitter derangement, with deficiencies of dopamine, noradrenaline and serotonin [<xref ref-type="bibr" rid="CR74">74</xref>]. Excess phenylalanine increases oxidant stress [<xref ref-type="bibr" rid="CR75">75</xref>], impairs cholesterol synthesis [<xref ref-type="bibr" rid="CR75">75</xref>] and activates osteoclasts [<xref ref-type="bibr" rid="CR76">76</xref>].</p>
<p id="Par52">PKU outcome was revolutionized by Horst Bickel’s therapeutic diet, still used today. Extreme natural-protein restriction, supplemented with micronutrient-fortified phenylalanine-free amino acid-based supplements to meet nutritional requirements was instituted neonatally [<xref ref-type="bibr" rid="CR74">74</xref>]. Close blood-spot monitoring of phenylalanine levels, maintained throughout development, has enabled attainment of near-potential IQ [<xref ref-type="bibr" rid="CR73">73</xref>]. Adherence to such dietary stringency is difficult for many; alternative therapies e.g. tetrahydrobiopterin (BH4) or Kuvan®, co-factor for PAH, may be limited to those with residual enzyme activity and/or access [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR77">77</xref>–<xref ref-type="bibr" rid="CR79">79</xref>]. Many adults, including women of childbearing age, are lost to follow-up, often due historically, to ceasing in adolescence or earlier [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>] This is concerning as excess maternal blood phenylalanine is highly teratogenic throughout gestation. Active placental phenylalanine transport further elevates foetal blood levels [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
</sec>
<sec id="FPar3">
<title>Maternal PKU syndrome</title>
<p id="Par53">In 1956, Charles Dent reported adverse neurological sequelae of maternal PKU in non-PKU children, suggesting toxicity of phenylalanine on foetal brain development [<xref ref-type="bibr" rid="CR80">80</xref>]. Prevention by gestational dietary phenylalanine restriction advised in Mabry’s landmark 1963 paper [<xref ref-type="bibr" rid="CR80">80</xref>], was trialled from mid-gestation in 1968, and preconception from 1979, while isolated case reports of microcephaly, intellectual disability, growth retardation and cardiac defects were published [<xref ref-type="bibr" rid="CR81">81</xref>].</p>
<p id="Par54">The full maternal PKU syndrome report in 1980, including biochemical threshold, reviewed published and unpublished data from all metabolic centres [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. This pivotal study reported offspring small for gestation age (SGA) in 40%, microcephaly in 73%, congenital heart disease in 12% and 92% were intellectually disabled [<xref ref-type="bibr" rid="CR82">82</xref>]. Recent meta-analysis by Prick 2012 confirmed these findings with lower prevalence likely due to <italic>inclusion</italic> of women with milder genotypes, manifest as hyperphenylalaninemia (HPA) and representing about 50% of the total PKU / HPA population, previously excluded from Lenke &amp; Levy’s original analysis. SGA was seen in in 19.2%, microcephaly in 46.2%, congenital heart disease in 6.6% and 46.9% were intellectually disabled. Facial dysmorphism was reported in 50% (odds ratio 4.0), the first trimester being the critical risk-period [<xref ref-type="bibr" rid="CR83">83</xref>].</p>
<p id="Par55">This underscores the importance of systematic data collection for rare disease registries, with pregnancy outcome <italic>including the long-term follow-up of children born to mothers with IEM.</italic></p>
</sec>
<sec id="FPar4">
<title>Contemporary management</title>
<p id="Par56">Current management was recently reviewed, revised and published in full [<xref ref-type="bibr" rid="CR73">73</xref>]. Compared with the non-pregnant target of &lt;600, European PKU pregnancy guidelines advocate a phenylalanine level of &lt;360 micromol/L (or &lt; 250 in many countries). This is based on the biochemical threshold for foetal vulnerability [<xref ref-type="bibr" rid="CR74">74</xref>], given active placental phenylalanine transport [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
<p id="Par57">Reproductive-age women with PKU or HPA, once identified, need referral to a specialist metabolic centre and/or a metabolic dietician. Pregnancies should be planned, and diet started preconception [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>].</p>
<p id="Par58">Phenylalanine control generally improves once nausea settles, second trimester protein tolerance increases with maternal and foetal anabolism, and third trimester foetal uptake of phenylalanine parallels accelerated growth, lowering maternal levels [<xref ref-type="bibr" rid="CR84">84</xref>]. With a PKU-affected foetus [<xref ref-type="bibr" rid="CR84">84</xref>], (G Wilcox &amp; D Green unpublished observations), maternal catabolism with impaired foetal phenylalanine uptake likely explains worsened phenylalanine control after 30 weeks’ gestation.</p>
<p id="Par59">Catabolism from intercurrent infections or antenatal corticosteroids and/or psycho-social issues hindering dietary compliance may worsen phenylalanine control. BH4 may complement existing management, if accessible, and the mother responsive [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR79">79</xref>].</p>
<p id="Par60">Post-partum resumption of usual diet is commonplace. Neuropsychiatric symptoms coincident with accelerated catabolism post-partum and high protein intake were reported anecdotally (personal communication Ian Chapman). Formal studies of post-natal depression in PKU are awaited. Breastfeeding is not contraindicated [<xref ref-type="bibr" rid="CR73">73</xref>].</p>
</sec>
<sec id="FPar5">
<title>Homocystinuria</title>
<p id="Par61">Genetic causes of hyper homocysteinaemia include cystathione beta synthase (CBS) deficiency or ‘classical homocystinuria’ (variably or not pyridoxine responsive) [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR86">86</xref>], methylene-tetra hydro-folate reductase (MTHFR) deficiency [<xref ref-type="bibr" rid="CR87">87</xref>] and cobalamin C (Cbl C) disease which results in combined methyl malonic acidaemia and homocystinuria due to deficient adenosyl-cobalamin [<xref ref-type="bibr" rid="CR88">88</xref>]. These conditions may differ in clinical features and severity [<xref ref-type="bibr" rid="CR86">86</xref>–<xref ref-type="bibr" rid="CR88">88</xref>] but all are associated with elevated homocysteine levels and increased thrombosis risk.</p>
<p id="Par62">Management includes co-factor replacement where relevant (e.g. B6 for B6 responsive CBS deficiency [<xref ref-type="bibr" rid="CR86">86</xref>], folate for MTHFR deficiency [<xref ref-type="bibr" rid="CR87">87</xref>] and B12 for Cbl C disease [<xref ref-type="bibr" rid="CR88">88</xref>]), betaine to enhance remethylation to methionine, and protein restriction if appropriate with provision of methionine–free amino acid supplementation [<xref ref-type="bibr" rid="CR86">86</xref>].</p>
<p id="Par63">The impact and management of these conditions in pregnancy has been reviewed previously [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]; the main complications are maternal venous thromboembolism during pregnancy and post-partum [<xref ref-type="bibr" rid="CR90">90</xref>]. MTHFR polymorphisms A1298C [<xref ref-type="bibr" rid="CR91">91</xref>] and C677T which are relatively mild and common in the general population have been variably associated with recurrent miscarriage, [<xref ref-type="bibr" rid="CR92">92</xref>–<xref ref-type="bibr" rid="CR96">96</xref>] and reduced in-vitro fertilization success [<xref ref-type="bibr" rid="CR97">97</xref>].</p>
<p id="Par64">These conditions are therefore managed as a form of thromobophilia, with anticoagulation from the either the third trimester of pregnancy until 6 weeks post-partum or throughout pregnancy and the puerperium, depending on local protocol [<xref ref-type="bibr" rid="CR5">5</xref>]. Since protein requirements increase during pregnancy, protein restrictions in place need adjustment to meet nutritional requirements.</p>
</sec>
<sec id="FPar6">
<title>Maple syrup urine disease</title>
<p id="Par65">Maple syrup urine disease (MSUD) is an inborn error of branched chain amino acid (BCAA) metabolism due to deficiency of the intra-mitochondrial thiamine-dependent enzyme complex, Branched Chain Keto Acid Decarboxylase. This converts the BCAA derived keto-acids into their respective Coenzyme A derivatives for subsequent mitochondrial energy production [<xref ref-type="bibr" rid="CR98">98</xref>–<xref ref-type="bibr" rid="CR100">100</xref>].</p>
<p id="Par66">Decompensation may occur with catabolic stress and/or excess protein intake, manifesting elevated BCAA, allo-isoleucine, and their respective keto-acids [<xref ref-type="bibr" rid="CR101">101</xref>]. Of the BCAA, leucine is particularly neurotoxic [<xref ref-type="bibr" rid="CR102">102</xref>], with isoleucine and valine significantly attenuating this [<xref ref-type="bibr" rid="CR102">102</xref>]. The urine may have a characteristic ‘maple syrup’ odour, attributed to isoleucine-derived sotolone [<xref ref-type="bibr" rid="CR103">103</xref>]. Clinical severity varies depending on the degree and type of enzyme deficiency. The most severe forms present neonatally, before newborn screening results return. Milder cases including ‘intermittent’ MSUD may not be diagnosed until adulthood. Newborn screening (NBS) programs should improve this outcome, long-term [<xref ref-type="bibr" rid="CR101">101</xref>]. However, most women currently of childbearing age may not have been screened neonatally for MSUD. Presentations may vary according to age of symptom onset. Ketosis with raised BCAA, nausea, vomiting and progressive encephalopathy are characteristic: irritability, ataxia, hyponatraemia, brain oedema, coma and death may occur if untreated [<xref ref-type="bibr" rid="CR104">104</xref>].</p>
<p id="Par67">Management is by dietary restriction of natural protein, supplemented with BCAA-free fortified amino acid and valine supplements with strict monitoring of BCAA levels. Milder forms of MSUD may be thiamine responsive [<xref ref-type="bibr" rid="CR99">99</xref>]. Long term suboptimal outcomes may be manifest by varying degrees of intellectual impairment and/or executive dysfunction [<xref ref-type="bibr" rid="CR104">104</xref>].</p>
<p id="Par68">In pregnancy, the risk periods are in the first trimester, where nausea and vomiting may result in catabolism from inadequate calorie intake, and post-partum when uterine involution increases the free amino acid pool. Intercurrent infections at any stage, and delivery by labour or caesarian section represent additional catabolic stressors.</p>
<p id="Par69">Death with cerebral oedema has been reported 51 days post-partum, confounded by concurrent physical trauma [<xref ref-type="bibr" rid="CR105">105</xref>], but successful pregnancies have been reported in the literature [<xref ref-type="bibr" rid="CR106">106</xref>–<xref ref-type="bibr" rid="CR109">109</xref>] as well as others (G Wilcox unpublished observations). Though rats, leucine-exposed neonatally, display long-term neuro-behavioural disturbance [<xref ref-type="bibr" rid="CR110">110</xref>], no adverse outcomes are yet described in the children of mothers with MSUD, despite poor compliance and suboptimal metabolic control in some [<xref ref-type="bibr" rid="CR108">108</xref>]. Leucine requirements increase disproportionately during late pregnancy [<xref ref-type="bibr" rid="CR17">17</xref>], which may be protective. Clearly longer-term follow-up of such offspring is warranted.</p>
</sec>
</sec>
<sec id="Sec15">
<title>Organic acidaemias</title>
<sec id="FPar7">
<title>‘Classical’ organic acidaemias</title>
<p id="Par70">Of the organic acidaemias, isovaleric acidaemia (IVA) propionic acidaemia (PA) and methylmalonic acidaemia (MMA) are well described, intra-mitochondrial inborn errors of BCAA metabolism. Precursor amino acids are leucine for IVA, and valine, methionine, isoleucine and threonine, in addition to odd-chain-length fatty acids, for PA and MMA [<xref ref-type="bibr" rid="CR104">104</xref>].</p>
<p id="Par71">These conditions have typically presented neonatally or in infancy with acute metabolic decompensation associated with anorexia, nausea, vomiting, high anion gap metabolic acidosis and hyperammonaemia leading to coma if untreated [<xref ref-type="bibr" rid="CR104">104</xref>]. Complications may appear in the post-acute recovery phase. Basal ganglia damage, neuropsychiatric symptoms, cardiomyopathy, pancreatitis, and more chronically, renal failure, may occur, especially in MMA [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR111">111</xref>]. Many of these latter complications may represent mitochondrial dysfunction, since the toxic byproducts may accumulate intra-mitochondrially [<xref ref-type="bibr" rid="CR112">112</xref>].</p>
<p id="Par72">Survival has improved markedly in the last 40 years due to better diagnosis, treatment and reduced morbidity, especially with the implementation of expanded NBS programs [<xref ref-type="bibr" rid="CR113">113</xref>]. However, most women currently of childbearing age have been born prior to expanded NBS.</p>
<p id="Par73">Management is by natural protein restriction and supplementation with non-precursor amino acids. Carnitine is prescribed to enhance renal excretion of these short-chain fatty acids (isovaleric acid or propionic acid). Antibiotics may be prescribed to reduce gut bacterial production of propionic acid in PA &amp; MMA. Some forms of MMA are vitamin B12 responsive and, with appropriate dosing, do not need significant dietary restriction [<xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR114">114</xref>].</p>
<p id="Par74">Successful pregnancies have been reported in IVA [<xref ref-type="bibr" rid="CR115">115</xref>–<xref ref-type="bibr" rid="CR118">118</xref>], PA [<xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR120">120</xref>] and MMA (both B12 responsive and non-responsive forms) [<xref ref-type="bibr" rid="CR121">121</xref>]. There are currently no studies to establish if subfertility is a problem or not.</p>
<p id="Par75">Potential challenges include maintaining adequate caloric intake, especially in PA and MMA where anorexia is common even in the non-pregnant state [<xref ref-type="bibr" rid="CR104">104</xref>], and avoidance of catabolism throughout pregnancy, labour, and the post-partum period, by providing adequate non-protein calories [<xref ref-type="bibr" rid="CR4">4</xref>]. Titration of protein intake and carnitine dosage may be needed alongside close metabolic and nutritional monitoring [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR121">121</xref>].</p>
<p id="Par76"><italic>IVA:</italic> There are four published case reports of isovaleric acidaemia in 8 pregnancies [<xref ref-type="bibr" rid="CR115">115</xref>–<xref ref-type="bibr" rid="CR118">118</xref>]. These were all successful and uncomplicated without post-partum decompensation. Plasma acyl carnitine monitoring showed variable decreases in gestational isovaleryl carnitine, reflecting decreased isovaleryl-CoA, from the second trimester as plasma leucine levels fell consistent with increased foetal anabolism, potentially conferring greater maternal metabolic stability [<xref ref-type="bibr" rid="CR117">117</xref>, <xref ref-type="bibr" rid="CR118">118</xref>].</p>
<p id="Par77"><italic>PA:</italic> There are currently 7 reported pregnancies in the literature [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR120">120</xref>], including 6 reviewed by Schwoerer et al. 2016 [<xref ref-type="bibr" rid="CR119">119</xref>]. Four of these were uncomplicated and none experienced post-partum metabolic decompensation. Two pregnancies in one woman were significantly pre-term, with pre-eclampsia in both, and IUGR in one. All pregnancies were in known patients and managed pro-actively, continuing usual therapies and given IV glucose, ± I-carnitine, peri-partum in 6/7 cases. Mungan et al. reported uncomplicated C-section and lactation [<xref ref-type="bibr" rid="CR120">120</xref>]. Unreported successful pregnancies have occurred [<xref ref-type="bibr" rid="CR119">119</xref>]. Current reports are insufficent to preclude a pregnancy risk nor determine whether the pre-eclampsia, IUGR and pre-term births reported by Schwoerer et al. are isolated findings [<xref ref-type="bibr" rid="CR119">119</xref>] or reflect PA-related placental mitochondrial stress.</p>
<p id="Par78"><italic>MMA:</italic> Outcome in isolated MMA has been reviewed in a recent case series [<xref ref-type="bibr" rid="CR121">121</xref>] (<italic>n</italic> = 17 with 13 completed pregnancies) including 9 additional cases from the literature; adding our own single case experience (Melbourne) totals 14 completed pregnancies. These reports encompass a spectrum of severity of MMA subtypes [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR121">121</xref>–<xref ref-type="bibr" rid="CR123">123</xref>], including one patient post renal transplant [<xref ref-type="bibr" rid="CR124">124</xref>].</p>
<p id="Par79">Complications reported include first trimester spontaneous abortions (3/18), increased Caesarean section rate (8/14 cases) for suspected foetal distress in 6/8, and renal function decline during pregnancy [<xref ref-type="bibr" rid="CR125">125</xref>] in 2 cases, persisting post-partum in our case (GWilcox unpublished observations). One patient had metabolic decompensation at 24 weeks gestation and another mild hyperammonaemia [<xref ref-type="bibr" rid="CR4">4</xref>]; in 4/13 birth weight was &lt;2500 g. These previously diagnosed patients were maintained on usual therapies including carnitine and vitamin B12, where applicable and given IV glucose [<xref ref-type="bibr" rid="CR121">121</xref>] or protein-free PN, peri-partum. No post-partum metabolic decompensations are reported, though our patient experienced transient unexplained dysphasia 5-6 weeks post-partum. Whether or not these obstetric complications relate to placental mitochondrial dysfunction in MMA warrants exploration. The long-term outcome of offspring from these pregnancies is to date unremarkable [<xref ref-type="bibr" rid="CR121">121</xref>].</p>
</sec>
<sec id="FPar8">
<title>Combined MMA &amp; homocystinuria</title>
<p id="Par80">Cobalamin C disease an inborn error of cobalamin (vitamin B12) metabolism causing elevation in both methylmalonic acid and homocysteine, is generally responsive to high dose to parenteral hydroxycobalamin therapy ± oral betaine [<xref ref-type="bibr" rid="CR88">88</xref>]. Despite optimal therapy, homocysteine remains elevated with attendant thromobosis, hence pregnancy, risk [<xref ref-type="bibr" rid="CR88">88</xref>]. Case reports of successful pregnancy with maintenance of high-dose cobalamin therapy and appropriate thromboprophylaxis, e.g. aspirin, are reported [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>]. Of note, nitrous oxide anaesthesia should be avoided given its toxic effect on B12 metabolism [<xref ref-type="bibr" rid="CR88">88</xref>].</p>
</sec>
<sec id="FPar9">
<title>‘Cerebral’ organic acidaemias</title>
<p id="Par81">This group of disorders are principally manifest by chronic neurological symptoms [<xref ref-type="bibr" rid="CR111">111</xref>]. Glutaric aciduria Type 1(Ga1), is the best characterized. An intra-mitochondrial disorder of lysine and tryptophan metabolism, its presentation is varied. Febrile illnesses in early childhood may trigger encephalopathic crises resulting striatal damage and complex movement disorders [<xref ref-type="bibr" rid="CR111">111</xref>]. NBS data has broadened the phenotypic spectrum and improved outcome [<xref ref-type="bibr" rid="CR128">128</xref>]. Three case reports of 4 well-managed pregnancies, 2 delivered by caesarean section, are reported [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR130">130</xref>]. Protein restriction, avoidance of catabolic stress peripartum by intravenous glucose ± lipid, continuation of carnitine therapy (parenterally if needed) with careful biochemical monitoring likely supported a favourable outcome. Screening programs have identified asymptomatic women with apparently unremarkable pregnancy histories [<xref ref-type="bibr" rid="CR130">130</xref>]. Three further untreated pregnancies in two women are reported. Neonatal carnitine deficiency lead to maternal GA1 diagnosis in one [<xref ref-type="bibr" rid="CR130">130</xref>]. MRI changes with Sylvian enlargement in two offspring at 4 months’ age and bilateral temporal arachnoid cysts in one are described. Development at 3 and 5 years was reportedly normal [<xref ref-type="bibr" rid="CR131">131</xref>]; clearly longer-term follow-up is needed.</p>
</sec>
</sec>
<sec id="Sec16">
<title>Inherited disorders of carbohydrate metabolism</title>
<p id="Par82">Disorders of carbohydrate metabolism encompass the glycogen storage diseases (GSD), disorders of fructose metabolism, galactosaemia and congenital disorders of glycosylation (CDG) [<xref ref-type="bibr" rid="CR32">32</xref>].</p>
<sec id="FPar10">
<title>Glycogen storage diseases (GSD)</title>
<p id="Par83">There are 20 described GSD differentially affecting liver, muscle, heart and brain [<xref ref-type="bibr" rid="CR132">132</xref>]. The hepatic (GSD 0, Ia, Ib, III, VI, IX &amp; XI), muscle (GSD II, V, VII &amp; X-XIV) and the muscle lysosomal GSD II, are amongst the better characterized. GSD III, affecting both liver and muscle, may be associated with cardiomyopathy [<xref ref-type="bibr" rid="CR133">133</xref>].</p>
<p id="Par84">The <italic>hepatic GSDs</italic> present with varying degrees of hypoglycaemia; chronic futile glycogenolysis and/or gluconeogenesis may cause deranged intermediary metabolism and end-organ damage. Frequent cornstarch and/or overnight tube feeding has enabled survival into adulthood in the more severe forms. Longer-term complications have emerged from the underlying conditions and their treatment. [<xref ref-type="bibr" rid="CR133">133</xref>] Obesity, insulin resistance and progression to type 2 diabetes are increasingly seen in hepatic GSD [<xref ref-type="bibr" rid="CR134">134</xref>].</p>
<p id="Par85">Pregnancy is problematic in hepatic GSD due to increased glucose demands and energy requirements, especially in GSD1, where glycaemia is totally dependent on exogenous glucose [<xref ref-type="bibr" rid="CR135">135</xref>–<xref ref-type="bibr" rid="CR137">137</xref>]. Published reviews and case series report successful outcome with close glucose monitoring and increased cornstarch and/or overnight feeding to maintain euglycaemia [<xref ref-type="bibr" rid="CR138">138</xref>, <xref ref-type="bibr" rid="CR139">139</xref>].</p>
<p id="Par86">Maternal complications reported in <italic>GSD1a</italic> (glucose-6-phosphatase deficiency) include increased frequency/severity of hypoglycaemia, renal function decline, peripartum lactic acidosis, worsened hypertriglyceridaemia and foetal IUGR, macrosomia and neonatal hypoglycaemia. Maternal hepatic adenomata did not increase in this case series. [<xref ref-type="bibr" rid="CR135">135</xref>]. Foetal death in utero at 33 weeks has been reported [<xref ref-type="bibr" rid="CR140">140</xref>]. Late presentation and poor metabolic control with severe proteinuria, hypertension, IUGR and foetal distress resulted in emergency C-section of 412 g infant at 26 weeks and neonatal death 2 days later [<xref ref-type="bibr" rid="CR141">141</xref>]. Progression of hepatic adenomata has been reported in GSD1b [<xref ref-type="bibr" rid="CR138">138</xref>].</p>
<p id="Par87">Survival in <italic>GSD 1b</italic> (glucose-6-phosphatase translocase deficiency), associated with neutrophil dysfunction, has followed availability of GCSF. Pregnancy outcomes have been reviewed [<xref ref-type="bibr" rid="CR136">136</xref>] with intercurrent infections in all 5 pregnancies, progressive increases in glucose requirement towards term, maternal albuminuria in 3/5 and respiratory distress in 3/5 term infants.</p>
<p id="Par88"><italic>GSD III (glycogen debranching enzyme deficiency</italic>) pregnancy outcome review [<xref ref-type="bibr" rid="CR142">142</xref>] reports successful pregnancies, though cardiomyopathy worsened in 1 of 3 affected women and 4/15 infants had very low birth weight including one with persistent neurodevelopmental problems, despite expert management. Gluconeogenesis is intact in GSDIII [<xref ref-type="bibr" rid="CR133">133</xref>]. How this impacts on already increased protein requirements late gestation [<xref ref-type="bibr" rid="CR8">8</xref>] has not yet been studied.</p>
<p id="Par89">Isolated <italic>muscle GSD</italic> such as McArdle’s (GSD V, myophosphorylase deficiency) in pregnancy have had limited review. The first full report of successful pregnancy and delivery in McArdle’s, reported in 1973, was essentially uncomplicated with minimal intervention [<xref ref-type="bibr" rid="CR143">143</xref>]. Further uncomplicated C-section deliveries [<xref ref-type="bibr" rid="CR144">144</xref>] with IV glucose [<xref ref-type="bibr" rid="CR145">145</xref>, <xref ref-type="bibr" rid="CR146">146</xref>], are reported; C-section plus calf compression, without IV glucose, was complicated by compartment syndrome post-partum [<xref ref-type="bibr" rid="CR147">147</xref>]. Retrospective review of 21 pregnancies by Findlay et al., reports minimal intervention and improved symptoms during pregnancy. Late gestational increased maternal lipid catabolism may be protective [<xref ref-type="bibr" rid="CR143">143</xref>].</p>
</sec>
<sec id="FPar11">
<title>Galactosaemia</title>
<p id="Par90">Of the galactosaemias ‘classical galactosaemia’ (due to galactose-1-phosphate pagesuridyltransferase deficiency or GALT deficiency) is the most common and managed by dietary restriction of lactose and galactose. This is associated with ovarian failure which may be primary or cause early secondary ovarian failure [<xref ref-type="bibr" rid="CR148">148</xref>–<xref ref-type="bibr" rid="CR150">150</xref>]. The exact mechanisms remain unclear but possibly occur in intrauterine life; secondary disturbances in glycosylation may occur [<xref ref-type="bibr" rid="CR151">151</xref>]. Successful spontaneous pregnancies have occurred, even with absent AMH [<xref ref-type="bibr" rid="CR152">152</xref>], and apparently without complications [<xref ref-type="bibr" rid="CR153">153</xref>].</p>
</sec>
<sec id="FPar12">
<title>Disorders of fructose metabolism</title>
<p id="Par91">Disorders of fructose metabolism include <italic>hereditary fructose intolerance (HFI)</italic> which may also be associated with secondary disturbance on glycosylation. One case report postulates maternal heterozygosity and gestational fructose ingestion leading to congenital abnormalities in a HFI affected foetus [<xref ref-type="bibr" rid="CR154">154</xref>]. HFI symptoms, seen in homozygotes for the Aldolase B mutation, are generally prevented by complete dietary fructose exclusion. Pregnancies with HFI are reported and, with fructose aversion, unremarkable [<xref ref-type="bibr" rid="CR155">155</xref>].</p>
<p id="Par92"><italic>Fructose 1,6 bisphosphatase deficiency</italic> is a disorder of gluconeogenesis manifest by hypoglycaemia and lactic acidosis, triggered by fructose ingestion or fasting. Krishnamurthy et al. reported 3 completed pregnancies; one patient subsequently developed sensorineural hearing loss and early cognitive impairment [<xref ref-type="bibr" rid="CR156">156</xref>].</p>
<p id="Par93"><italic>Congenital disorders of glycosylation</italic> are frequently associated with reduced fertility possibly due to altered glycosylation of peptide hormones [<xref ref-type="bibr" rid="CR157">157</xref>]. ‘Mirror syndrome’ with maternal oedema in the setting of hydrops foetalis has been reported in two pregnancies where the foetus was later diagnosed with CDG 1a [<xref ref-type="bibr" rid="CR158">158</xref>]. This represents an example of a foetal IEM affecting the mother.</p>
</sec>
</sec>
<sec id="Sec17">
<title>Inherited disorders of cholesterol metabolism</title>
<p id="Par94"><italic>Smith Lemli Opitz syndrome</italic>, an IEM of cholesterol synthesis, causes 7 &amp; 8 dehydro-cholesterol accumulation, Sonic Hedgehog signaling pathway disruption with characteristic dysmorphic features, autistic spectrum disorder and variable intellectual disability. Treatments, with limited evidence-base include cholesterol and/or statin therapy. Successful pregnancy reported in a mild case, was managed with dietary cholesterol loading from 29 weeks [<xref ref-type="bibr" rid="CR159">159</xref>].</p>
<sec id="FPar13">
<title>Abetalipoproteinaemia</title>
<p id="Par95">This LDL synthesis disorder severely impairs absorption, transport and delivery of cholesterol and fat-soluble vitamins, especially Vitamin E. Treatment requires administration of high-dose fat-soluble vitamins. Adverse pregnancy outcomes are reported with poor compliance to fat soluble vitamin replacement [<xref ref-type="bibr" rid="CR160">160</xref>–<xref ref-type="bibr" rid="CR162">162</xref>]. Conversely successful outcome has been reported with adequate vitamin replacement and monitoring [<xref ref-type="bibr" rid="CR163">163</xref>]. Vitamin A replacement should be continued to maintain adequate levels, as deficiency, as well as excess, can result in adverse foetal outcome [<xref ref-type="bibr" rid="CR162">162</xref>].</p>
</sec>
</sec>
</sec>
<sec id="Sec18">
<title>Inborn errors of mitochondrial energy metabolism</title>
<p id="Par96">Substantially increasing energy requirements during pregnancy, particularly for mitochondrial-rich organs such as heart, kidneys, liver and placenta, renders energy supply pivotal. Mitochondrial energy metabolism may be affected by disorders of ketogenesis and ketolysis, mitochondrial fatty acid oxidation, and disorders of the respiratory chain including those resulting from maternally-inherited mitochondrial DNA mutations [<xref ref-type="bibr" rid="CR32">32</xref>].</p>
<sec id="Sec19">
<title>Disorders of ketogenesis &amp; ketolysis</title>
<p id="Par97">Variable pregnancy outcomes have been reported in this group [<xref ref-type="bibr" rid="CR164">164</xref>]. Early gestational fasting ketone availability and utilization is critical, especially if nausea and vomiting limits intake.</p>
<p id="Par98">In <italic>HMG CoA Lyase deficiency</italic>, prone to hypoketotic hypoglycaemia and metabolic acidosis, early foetal losses and maternal death at 9 weeks gestation were reported [<xref ref-type="bibr" rid="CR4">4</xref>]. A successful pregnancy was managed with L-carnitine, protein-intake adjustment and glucose calories [<xref ref-type="bibr" rid="CR123">123</xref>]. Despite IV 10% glucose and IV L-carnitine, decompensation occurred during labour, necessitating emergency C-section [<xref ref-type="bibr" rid="CR123">123</xref>]. Two further successful pregnancies recently reported, were managed by oral glucose, carnitine and overnight cornstarch during pregnancy, with planned C-Section and total parenteral nutrition peri- and post-partum providing &gt;2000 Kcal per day. This provided sufficient calories in the face of potent catabolic stress and increased energy requirements [<xref ref-type="bibr" rid="CR165">165</xref>].</p>
<p id="Par99"><italic>Defects of ketolysis</italic> can result in excessive ketosis. Emergency C-section at term for foetal bradycardia was reported in a woman with <italic>beta-ketothiolase deficiency</italic> [<xref ref-type="bibr" rid="CR166">166</xref>]. These disorders, and pregnancy considerations, are reviewed [<xref ref-type="bibr" rid="CR164">164</xref>].</p>
</sec>
<sec id="Sec20">
<title>Disorders of mitochondrial fatty acid oxidation</title>
<p id="Par100">These disorders exemplify how a foetal IEM may impact on the mother, and the insights a rare condition may bring to the wider field.</p>
<p id="Par101">The association of maternal Acute Fatty Liver of Pregnancy (AFLP) and/or Haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome with foetal Long Chain Hydroxy Acyl CoA Dehydrogenase deficiency (LCHAD) first noted in 1991, has been extensively studied [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR167">167</xref>] and recently reviewed [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
<p id="Par102"><italic>Foetal homozygosity for the LCHAD enzyme includes the placenta</italic>. Incomplete mitochondrial beta-oxidation leaves residual substrate being catalyzed by alternative pathways in peroxisomes and microsomes. Peroxisomal, unlike mitochondrial, beta-oxidation, does not yield ATP. Instead, by-products of blocked pathways yield peroxide radicals and other pro-oxidant species, further compromising placental mitochondrial function. Since foetal and maternal placental circulations, are juxtaposed, toxic by-products freely enter the maternal circulation where effects on foetal sub-cellular metabolism are mirrored in maternal organs [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR29">29</xref>] Fig. <xref ref-type="fig" rid="Fig4">4</xref>. The maternal LCHAD heterozygote may be more vulnerable to mitochondrial dysfunction, including beta-oxidation [<xref ref-type="bibr" rid="CR29">29</xref>]. Compromised hepatic mitochondrial function likely underlies acute fatty liver of pregnancy (AFLP) [<xref ref-type="bibr" rid="CR168">168</xref>]. Other maternal organs may be affected. Pancreatitis, renal dysfunction and cerebral effects may be seen [<xref ref-type="bibr" rid="CR29">29</xref>]. Pathophysiological derangements encompassing the clinical spectrum of AFLP and HELLP to pre-eclampsia are reported [<xref ref-type="bibr" rid="CR29">29</xref>]. Other foetal [<xref ref-type="bibr" rid="CR169">169</xref>–<xref ref-type="bibr" rid="CR172">172</xref>] and maternal [<xref ref-type="bibr" rid="CR169">169</xref>, <xref ref-type="bibr" rid="CR173">173</xref>] FAOD are reported with these syndromes.<fig id="Fig4"><label>Fig. 4</label><caption><p><bold>Mitochondrial fatty acid β oxidation pathway &amp; interplay between foeto-placental and maternal metabolism in LCHAD.</bold> Classical β-oxidation pathway involves: dehydrogenase by acyl-CoA dehydrogenase and hydration, dehydrogenation and thiolyic cleavage is catalyzed by the -mitochondrial trifunctional protein (MTP, highlighted in red color). MTP consists of: enoyl-CoA hydratase,hydroxy acyl-CoA dehydrogenase &amp; thiolase activity. The straight arrows represent products and bent arrows represent the involvement of co-factor in this enzyme-catalyzed reaction. Fetal long chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) deficiency results in accumulation of 3-hydroxy fatty acids in the placenta, since the fetal part of placenta is identical to the genetic makeup of the fetus. Increased accumulation of placental free fatty acids and 3-hydroxy fatty acyl-CoA cause oxidative stress, mitochondrial dysfunction and placental lipotoxicity. Further, lipolysis induced in the third trimester of pregnancy would also trigger the accumulation of fatty acid intermediates, which are shunted from the placenta to the maternal circulation, where they can promote oxidative and nitrosative stress. These fatty acid intermediates reach the maternal liver resulting in microvesicular steatosis, hepatic mitochondrial dysfunction and hepatocyte lipoapoptosis. Source: Adapted from Natarajan &amp; Ibdah (reference [<xref ref-type="bibr" rid="CR29">29</xref>]) Int J Mol Sci. 2018 Jan; 19(1): 322. Published online 2018 Jan 22. doi: 10.3390/ijms19010322</p></caption><graphic id="MO4" xlink:href="11154_2018_9455_Fig4_HTML"></graphic></fig></p>
<p id="Par103">Accumulating evidence suggests placental mitochondrial dysfunction may in fact underlie many pathological conditions in pregnancy [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR174">174</xref>–<xref ref-type="bibr" rid="CR179">179</xref>] (Tables <xref ref-type="table" rid="Tab2">2</xref> &amp; <xref ref-type="table" rid="Tab3">3</xref><italic>).</italic><table-wrap id="Tab2"><label>Table 2</label><caption><p>Mitochondrial dysfunction in IEM with implications for pregnancy</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Primary disorders of mitochondrial energy metabolism</th><th>Mitochondrial dysfunction secondary to IEM</th></tr></thead><tbody><tr><td colspan="2">Mitochondrial DNA<sup>a</sup></td></tr><tr><td>
<italic>Respiratory chain disorders:</italic>
</td><td>
<italic>Urea Cycle Disorders</italic>
<sup><italic>c</italic></sup>
<italic>:</italic>
</td></tr><tr><td>MELAS</td><td>OTC deficiency</td></tr><tr><td rowspan="2">Chronic Progressive External Ophthalmoplegia</td><td>CPS deficiency</td></tr><tr><td>Citrullinaemia</td></tr><tr><td>Autosomal</td><td>
<italic>Organic acidaemias</italic>
<sup><italic>d</italic></sup>
<italic>:</italic>
</td></tr><tr><td>
<italic>Mitochondrial FAOD</italic>
<sup><italic>b</italic></sup>
<italic>:</italic>
</td><td rowspan="2">Isovaleric acidaemia</td></tr><tr><td>SCAD</td></tr><tr><td>MCAD</td><td>Propionic acidaemia</td></tr><tr><td>VLCAD</td><td rowspan="2">Methyl malonic acidaemia</td></tr><tr><td>LCHAD</td></tr><tr><td>CPT1</td><td rowspan="2"><italic>Cerebral organic acidaemias</italic><sup><italic>d</italic></sup>:</td></tr><tr><td>CPT2</td></tr><tr><td>MADD<sup>e</sup></td><td>Glutaric aciduria Type 1</td></tr></tbody></table><table-wrap-foot><p>References <sup>a</sup> [<xref ref-type="bibr" rid="CR180">180</xref>] <sup>b</sup> [<xref ref-type="bibr" rid="CR21">21</xref>], <sup>c</sup> [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR111">111</xref>, <xref ref-type="bibr" rid="CR112">112</xref>]</p><p><sup>e</sup>Creanza A JIMD Rep. 2017 Jul 7. doi: 10.1007/8904_2017_38</p><p><italic>MELAS</italic> Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes; <italic>FAOD</italic> Fatty acid oxidation disorders; <italic>SCAD</italic> Short<bold>-</bold>chain acyl-CoA dehydrogenase deficiency; <italic>MCAD</italic> Medium-chain acyl-CoA dehydrogenase deficiency; <italic>VLCAD</italic> Very long-chain acyl-CoA dehydrogenase deficiency; <italic>LCHAD</italic> Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency; <italic>CPT1</italic> Carnitine palmitoyltransferase I deficiency; <italic>CPT2</italic> Carnitine palmitoyltransferase II deficiency; <italic>MADD</italic> Multiple Acyl-CoA Dehydrogenase Deficiency or Glutaric aciduria Type 2</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>Acquired causes of mitochondrial dysfunction which may impact on pregnancy</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Acquired mitochondrial dysfunction</th><th>Potential mechanism(s)</th></tr></thead><tbody><tr><td colspan="2">Viruses</td></tr><tr><td> Influenza A<sup>a</sup><break></break> Influenza B<sup>b</sup><break></break> Hepatitis C virus<sup>c</sup><break></break> Human Immunodeficiency Virus (HIV)<sup>c</sup></td><td>Inflammatory cytokines ↓ mitochondrial fatty acid oxidation enzyme activity<break></break>Oxidative stress and Δ mtDNA<break></break>mtDNA depletion &amp; apoptosis</td></tr><tr><td colspan="2">Nutrient deficiencies<sup>d</sup></td></tr><tr><td> Hypoxia &amp; ischaemia</td><td>↓cellular respiration</td></tr><tr><td> ↓phosphate</td><td rowspan="2">↓ATP production</td></tr><tr><td> ↓ magnesium</td></tr><tr><td> Thiamine deficiency</td><td>↓Pyruvate Dehydrogenase function</td></tr><tr><td> Riboflavin deficiency</td><td rowspan="2">↓Respiratory chain function</td></tr><tr><td> Niacin deficiency</td></tr><tr><td> Carnitine deficiency</td><td>↓β oxidation of long chain fatty acids</td></tr><tr><td colspan="2">Endocrine disorders</td></tr><tr><td> Hypothyroidism<sup>e</sup></td><td>↓β oxidation of long chain fatty acids via ↓carnitine</td></tr><tr><td colspan="2">Drugs of abuse</td></tr><tr><td> Tobacco smoking<sup>c</sup></td><td>CO ↓cellular respiration<break></break>respiratory chain complex III ↓</td></tr><tr><td> Ethanol<sup>c</sup></td><td>Altered NADH/NAD+ redox state</td></tr><tr><td colspan="2">Therapeutic drugs</td></tr><tr><td> Anaesthetic agents:<break></break> propafol<sup>c</sup></td><td>Inhibits complex 1 of the respiratory chain</td></tr></tbody></table><table-wrap-foot><p><italic>mtDNA</italic> mitochondrial DNA; NADH/NAD+ = nicotinamide adenine dinucleotide hydride in reduced/oxidized states; <italic>ATP</italic> Adenosine triphosphate</p><p><italic>Sources:</italic>
<sup>a</sup> [<xref ref-type="bibr" rid="CR175">175</xref>], <sup>b</sup> [<xref ref-type="bibr" rid="CR176">176</xref>], <sup>c</sup> [<xref ref-type="bibr" rid="CR179">179</xref>], <sup>d</sup> [<xref ref-type="bibr" rid="CR100">100</xref>]</p></table-wrap-foot></table-wrap></p>
<p id="Par104">Recently, <italic>maternal</italic> LCHAD, with foetal heterozygosity, was reported. Pregnancy was initially uncomplicated. At 32 weeks’ gestation, maternal tachycardia, raised CK and lactate responded temporarily to increased medium chain triglyceride (MCT) oil dosage. Recurrent tachycardia determined C-section at 34 weeks. Acylcarnitine profile, improved in early pregnancy, had deteriorated, likely reflecting late gestational accelerated lipolysis [<xref ref-type="bibr" rid="CR181">181</xref>].</p>
<p id="Par105">Interestingly <italic>maternal VLCAD</italic> may stabilize with an unaffected foetus demonstrating the quantitative importance of placental beta oxidation of long chain fatty acids [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR169">169</xref>, <xref ref-type="bibr" rid="CR182">182</xref>].</p>
<p id="Par106"><italic>Systemic carnitine deficiency</italic> in pregnancy has been associated with decreased stamina and cardiac arrhythmia [<xref ref-type="bibr" rid="CR183">183</xref>].</p>
</sec>
</sec>
<sec id="Sec21">
<title>Organelle-based disorders</title>
<sec id="Sec22">
<title>Primary mitochondrial disorders</title>
<p id="Par107">Pregnancy complications are reported in mitochondrial IEM. Most publications relate to MELAS. A retrospective case series by De Laat [<xref ref-type="bibr" rid="CR180">180</xref>] reports premature delivery rates of 23.5% (5/23 &lt; 32 weeks), pre-eclampsia 12% and gestational diabetes mellitus 11%. Other case reports include neuromuscular deterioration and lactic acidosis [<xref ref-type="bibr" rid="CR184">184</xref>], status epilepticus [<xref ref-type="bibr" rid="CR185">185</xref>], pulmonary oedema [<xref ref-type="bibr" rid="CR186">186</xref>], pre-eclampsia [<xref ref-type="bibr" rid="CR187">187</xref>, <xref ref-type="bibr" rid="CR188">188</xref>] with magnesium sulphate infusion sensitivity [<xref ref-type="bibr" rid="CR189">189</xref>] and post-partum pulmonary embolism [<xref ref-type="bibr" rid="CR190">190</xref>]. These complications likely represent precarious placental function in mitochondrial disease and gestational energetic strain on vital maternal organs.</p>
</sec>
<sec id="Sec23">
<title>Peroxisomal disorders</title>
<p id="Par108">These include Refsum’s disease, a disorder of branched-chain fatty acid oxidation, with both infantile and adult-onset forms. Chloroplast-derived phytanic acid, from ruminant fat, cannot be metabolized, accumulating in the nervous system affecting hearing, retinal function, peripheral nerves. Phytanic acid levels are managed by diet-restriction ± plasmapheresis and avoidance of lipolysis, which can release phytanic acid from adipose tissue triggering neurological decompensation. A childhood-onset Refsum’s disease pregnancy, reporting reduced phytanic acid control late gestation, despite close dietetic management [<xref ref-type="bibr" rid="CR191">191</xref>], likely reflected accelerated lipolysis [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p>
</sec>
<sec id="Sec24">
<title>Lysosomal storage disorders</title>
<p id="Par109">This large group of IEM includes Gaucher’s disease, Fabry’s Disease, Pompe Disease (GSD II- a lysosomal muscle GSD) as well as the Mucopolysaccharidoses (MPS) and related disorders [<xref ref-type="bibr" rid="CR32">32</xref>]. There are, currently, recombinant lysosomal enzyme replacement therapies (ERT) for many of these conditions as well as emerging treatments such as substrate reduction, chaperone and gene therapies [<xref ref-type="bibr" rid="CR192">192</xref>]. Successful pregnancies are reported, including for Gaucher [<xref ref-type="bibr" rid="CR193">193</xref>, <xref ref-type="bibr" rid="CR194">194</xref>], Fabry [<xref ref-type="bibr" rid="CR195">195</xref>], Pompe [<xref ref-type="bibr" rid="CR196">196</xref>] and MPS disorders [<xref ref-type="bibr" rid="CR197">197</xref>–<xref ref-type="bibr" rid="CR199">199</xref>]. ERTs do not cross the placenta and have been given in pregnancy without complications [<xref ref-type="bibr" rid="CR198">198</xref>–<xref ref-type="bibr" rid="CR200">200</xref>]. Disease-specific registries exist, from which basic pregnancy data could be derived. Pompe disease has been associated with transiently worsening muscle weakness late gestation [<xref ref-type="bibr" rid="CR201">201</xref>]. Patients with MPS now reach adulthood in increasing numbers; the pregnancy experience in this group was recently reviewed [<xref ref-type="bibr" rid="CR197">197</xref>].</p>
</sec>
</sec>
</sec>
<sec id="Sec25">
<title>Conclusions</title>
<p id="Par110">This review is not exhaustive and there remain significant gaps in the literature, with many pregnancies not recorded; some areas reviewed elsewhere are not covered here and others where information is extremely limited. There is an urgent need for systematic data collection with an international registry of all pregnancies, and follow-up of all offspring, associated with maternal IEM. Long-term effects of either the primary metabolic disorder or the nutritional and/or pharmacological management warrant investigation. Long-term benefits of expanded newborn screening programs should be examined. Undiagnosed IEM may need consideration where there is hyperemesis gravidarum, liver failure or neuropsychiatric disturbance. The convergence of understanding between complications of various IEM in pregnancy, as well as acquired disorders, is intriguing. Advancing the pathophysiology and management of these rare IEM may illuminate mechanisms underlying more common conditions such as pre-eclampsia, gestational diabetes, and intra uterine growth retardation.</p>
</sec>
</body>
<back>
<fn-group>
<fn id="Fn1">
<label>1</label>
<p id="Par46">Goldstein R, Smith N, Strauss BJG &amp; Wilcox G. “Protein aversion and disordered eating in OTC deficiency: a challenge for pregnancy and post-partum management in a female heterozygote” 25th DMIMD, London, UK April 2011</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>Prof Boyd JG Strauss for assistance with graphics and proofreading.</p>
</ack>
<notes notes-type="COI-statement">
<sec id="FPar14">
<title>Conflict of interest</title>
<p>The author has received travel grants from Genzyme, Biomarin, Alexion and Shire, speaker honoraria from Vitaflo, Biomarin, Shire and Nutricia, research grants from the MPS society (UK), and advisory board membership with Biomarin, Medical Advisory Panel membership for the National Society for PKU (NSPKU) and consultancies for Dimension Therapeutics.</p>
</sec>
<sec id="FPar15">
<title>Informed consent</title>
<p>Informed consent was obtained from those individuals presented in case reports cited and authored by the author. Identifiable individual data has been removed from unpublished data presented.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sirrs</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hollak</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Merkel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sechi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Glamuzina</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The frequencies of different inborn errors of metabolism in adult metabolic Centres: Report from the SSIEM adult metabolic physicians group</article-title>
<source/>JIMD Rep
          <year>2016</year>
<volume>27</volume>
<fpage>85</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1007/8904_2015_435</pub-id>
<pub-id pub-id-type="pmid">26450566</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<mixed-citation publication-type="other">Hollak C, Lachmann R. In: Hollak C, Lachmann R, editors. Inherited metabolic disease in adults: a clinical guide (Oxford monographs on medical genetics). Oxford: Oxford University Press; 2016. p. xiii–ix.</mixed-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<mixed-citation publication-type="other">Erikson EH, editor. Youth: change and challenge. New York: Basic Books; 1963.</mixed-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langendonk</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Roos</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Angus</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karstens</surname>
<given-names>FP</given-names>
</name>
<name>
<surname>de Klerk</surname>
<given-names>JB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A series of pregnancies in women with inherited metabolic disease</article-title>
<source/>J Inherit Metab Dis
          <year>2012</year>
<volume>35</volume>
<issue>3</issue>
<fpage>419</fpage>
<lpage>424</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-011-9389-2</pub-id>
<pub-id pub-id-type="pmid">21918856</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Medical problems in obstetrics: Inherited metabolic disease</article-title>
<source/>Best Pract Res Clin Obstet Gynaecol
          <year>2015</year>
<volume>29</volume>
<issue>5</issue>
<fpage>707</fpage>
<lpage>720</lpage>
<pub-id pub-id-type="doi">10.1016/j.bpobgyn.2015.04.006</pub-id>
<pub-id pub-id-type="pmid">26088792</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Widen</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Body composition changes in pregnancy: Measurement, predictors and outcomes</article-title>
<source/>Eur J Clin Nutr
          <year>2014</year>
<volume>68</volume>
<issue>6</issue>
<fpage>643</fpage>
<lpage>652</lpage>
<pub-id pub-id-type="doi">10.1038/ejcn.2014.40</pub-id>
<pub-id pub-id-type="pmid">24667754</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>King</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Physiology of pregnancy and nutrient metabolism</article-title>
<source/>Am J Clin Nutr
          <year>2000</year>
<volume>71</volume>
<issue>5 Suppl</issue>
<fpage>1218s</fpage>
<lpage>1225s</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/71.5.1218s</pub-id>
<pub-id pub-id-type="pmid">10799394</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elango</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>RO</given-names>
</name>
</person-group>
<article-title>Protein and Amino Acid Requirements during Pregnancy</article-title>
<source/>Adv Nutr
          <year>2016</year>
<volume>7</volume>
<issue>4</issue>
<fpage>839s</fpage>
<lpage>844s</lpage>
<pub-id pub-id-type="doi">10.3945/an.115.011817</pub-id>
<pub-id pub-id-type="pmid">27422521</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>EL</given-names>
</name>
</person-group>
<article-title>Alterations in physiology and anatomy during pregnancy</article-title>
<source/>Best Pract Res Clin Obstet Gynaecol
          <year>2013</year>
<volume>27</volume>
<issue>6</issue>
<fpage>791</fpage>
<lpage>802</lpage>
<pub-id pub-id-type="doi">10.1016/j.bpobgyn.2013.08.001</pub-id>
<pub-id pub-id-type="pmid">24012425</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kovacs</surname>
<given-names>CS</given-names>
</name>
</person-group>
<article-title>Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery</article-title>
<source/>Physiol Rev
          <year>2016</year>
<volume>96</volume>
<issue>2</issue>
<fpage>449</fpage>
<lpage>547</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00027.2015</pub-id>
<pub-id pub-id-type="pmid">26887676</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<mixed-citation publication-type="other">Tolman KG, Rej R. In: Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry. 3rd ed. Philadelphia: Saunders; 1999. p. 1125–77.</mixed-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<mixed-citation publication-type="other">Herrera E, Desoye G. Maternal and fetal lipid metabolism under normal and gestational diabetic conditions. Horm Mol Biol Clin Invest. 2016:109.</mixed-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Metabolic adaptations in pregnancy: A review</article-title>
<source/>Ann Nutr Metab
          <year>2017</year>
<volume>70</volume>
<issue>1</issue>
<fpage>59</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1159/000459633</pub-id>
<pub-id pub-id-type="pmid">28297696</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herrera</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus</article-title>
<source/>Eur J Clin Nutr
          <year>2000</year>
<volume>54</volume>
<issue>Suppl 1</issue>
<fpage>S47</fpage>
<lpage>S51</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ejcn.1600984</pub-id>
<pub-id pub-id-type="pmid">10805038</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jansson</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Amino acid transporters in the human placenta</article-title>
<source/>Pediatr Res
          <year>2001</year>
<volume>49</volume>
<issue>2</issue>
<fpage>141</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1203/00006450-200102000-00003</pub-id>
<pub-id pub-id-type="pmid">11158505</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cleal</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>The mechanisms and regulation of placental amino acid transport to the human foetus</article-title>
<source/>J Neuroendocrinol
          <year>2008</year>
<volume>20</volume>
<issue>4</issue>
<fpage>419</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2826.2008.01662.x</pub-id>
<pub-id pub-id-type="pmid">18266945</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindsay</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Hellmuth</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Uhl</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Buss</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wadhwa</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Koletzko</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Longitudinal Metabolomic profiling of amino acids and lipids across healthy pregnancy</article-title>
<source/>PLoS One
          <year>2015</year>
<volume>10</volume>
<issue>12</issue>
<fpage>e0145794</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0145794</pub-id>
<pub-id pub-id-type="pmid">26716698</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delplancke</surname>
<given-names>TDJ</given-names>
</name>
<name>
<surname>de Seymour</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sulek</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of sequential hair segments reflects changes in the metabolome across the trimesters of pregnancy</article-title>
<source/>Sci Rep
          <year>2018</year>
<volume>8</volume>
<issue>1</issue>
<fpage>36</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-18317-7</pub-id>
<pub-id pub-id-type="pmid">29311683</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Payne</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stephens</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>RO</given-names>
</name>
<name>
<surname>Pencharz</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Elango</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Lysine requirements of healthy pregnant women are higher during late stages of gestation compared to early gestation</article-title>
<source/>J Nutr
          <year>2018</year>
<volume>148</volume>
<issue>1</issue>
<fpage>94</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1093/jn/nxx034</pub-id>
<pub-id pub-id-type="pmid">29378056</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cetin</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Alvino</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cardellicchio</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Long chain fatty acids and dietary fats in fetal nutrition</article-title>
<source/>J Physiol
          <year>2009</year>
<volume>587</volume>
<issue>Pt 14</issue>
<fpage>3441</fpage>
<lpage>3451</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2009.173062</pub-id>
<pub-id pub-id-type="pmid">19528253</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ibdah</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Acute fatty liver of pregnancy: An update on pathogenesis and clinical implications</article-title>
<source/>World J Gastroenterol
          <year>2006</year>
<volume>12</volume>
<issue>46</issue>
<fpage>7397</fpage>
<lpage>7404</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v12.i46.7397</pub-id>
<pub-id pub-id-type="pmid">17167825</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bustamante</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ramirez-Velez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Czerniczyniec</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cicerchia</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Aguilar de Plata AC, Lores-Arnaiz S. Oxygen metabolism in human placenta mitochondria</article-title>
<source/>J Bioenerg Biomembr
          <year>2014</year>
<volume>46</volume>
<issue>6</issue>
<fpage>459</fpage>
<lpage>469</lpage>
<pub-id pub-id-type="doi">10.1007/s10863-014-9572-x</pub-id>
<pub-id pub-id-type="pmid">25234730</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolahi</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Valent</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Thornburg</surname>
<given-names>KL</given-names>
</name>
</person-group>
<article-title>Cytotrophoblast, not Syncytiotrophoblast, Dominates Glycolysis and Oxidative Phosphorylation in Human Term Placenta</article-title>
<source/>Sci Rep
          <year>2017</year>
<volume>7</volume>
<fpage>42941</fpage>
<pub-id pub-id-type="doi">10.1038/srep42941</pub-id>
<pub-id pub-id-type="pmid">28230167</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bobinski</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mikulska</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The ins and outs of maternal-fetal fatty acid metabolism</article-title>
<source/>Acta Biochim Pol
          <year>2015</year>
<volume>62</volume>
<issue>3</issue>
<fpage>499</fpage>
<lpage>507</lpage>
<pub-id pub-id-type="doi">10.18388/abp.2015_1067</pub-id>
<pub-id pub-id-type="pmid">26345097</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Wadsack</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Desoye</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Placental fatty acid transfer</article-title>
<source/>Curr Opin Clin Nutr Metab Care
          <year>2018</year>
<volume>21</volume>
<issue>2</issue>
<fpage>78</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1097/MCO.0000000000000443</pub-id>
<pub-id pub-id-type="pmid">29206689</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gil-Sanchez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Koletzko</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Larque</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Current understanding of placental fatty acid transport</article-title>
<source/>Curr Opin Clin Nutr Metab Care
          <year>2012</year>
<volume>15</volume>
<issue>3</issue>
<fpage>265</fpage>
<lpage>272</lpage>
<pub-id pub-id-type="doi">10.1097/MCO.0b013e3283523b6e</pub-id>
<pub-id pub-id-type="pmid">22450774</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<mixed-citation publication-type="other">Waterham HR, Wanders RJ. Metabolic functions and biogenesis of peroxisomes in health and disease. Biochim Biophys Acta. 1822. Netherlands 2012. p. 1325.</mixed-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seymour</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Angove</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Snelling</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Cassey</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Scaling of cerebral blood perfusion in primates and marsupials</article-title>
<source/>J Exp Biol
          <year>2015</year>
<volume>218</volume>
<issue>Pt 16</issue>
<fpage>2631</fpage>
<lpage>2640</lpage>
<pub-id pub-id-type="doi">10.1242/jeb.124826</pub-id>
<pub-id pub-id-type="pmid">26113137</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Natarajan</surname>
<given-names>Sathish</given-names>
</name>
<name>
<surname>Ibdah</surname>
<given-names>Jamal</given-names>
</name>
</person-group>
<article-title>Role of 3-Hydroxy Fatty Acid-Induced Hepatic Lipotoxicity in Acute Fatty Liver of Pregnancy</article-title>
<source/>International Journal of Molecular Sciences
          <year>2018</year>
<volume>19</volume>
<issue>1</issue>
<fpage>322</fpage>
<pub-id pub-id-type="doi">10.3390/ijms19010322</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wray</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Insights from physiology into myometrial function and dysfunction</article-title>
<source/>Exp Physiol
          <year>2015</year>
<volume>100</volume>
<issue>12</issue>
<fpage>1468</fpage>
<lpage>1476</lpage>
<pub-id pub-id-type="doi">10.1113/EP085131</pub-id>
<pub-id pub-id-type="pmid">26289390</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mak</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>CW</given-names>
</name>
</person-group>
<article-title>Inborn errors of metabolism and expanded newborn screening: Review and update</article-title>
<source/>Crit Rev Clin Lab Sci
          <year>2013</year>
<volume>50</volume>
<issue>6</issue>
<fpage>142</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="doi">10.3109/10408363.2013.847896</pub-id>
<pub-id pub-id-type="pmid">24295058</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="book">
<person-group person-group-type="editor">
<name>
<surname>Saudubray</surname>
<given-names>Jean-Marie</given-names>
</name>
<name>
<surname>Baumgartner</surname>
<given-names>Matthias R.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>John</given-names>
</name>
</person-group>
<source/>Inborn Metabolic Diseases
          <year>2016</year>
<publisher-loc>Berlin, Heidelberg</publisher-loc>
<publisher-name>Springer Berlin Heidelberg</publisher-name>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bigot</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tchan</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Thoreau</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Blasco</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Maillot</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Liver involvement in urea cycle disorders: a review of the literature</article-title>
<source/>J Inherit Metab Dis
          <year>2017</year>
<volume>40</volume>
<issue>6</issue>
<fpage>757</fpage>
<lpage>769</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-017-0088-5</pub-id>
<pub-id pub-id-type="pmid">28900784</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<mixed-citation publication-type="other">Tchan M. Hyperammonemia and lactic acidosis in adults: Differential diagnoses with a focus on inborn errors of metabolism. Rev Endocr Metab Disord. 2018;</mixed-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schlune</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vom Dahl</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Haussinger</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ensenauer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mayatepek</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Hyperargininemia due to arginase I deficiency: The original patients and their natural history, and a review of the literature</article-title>
<source/>Amino Acids
          <year>2015</year>
<volume>47</volume>
<issue>9</issue>
<fpage>1751</fpage>
<lpage>1762</lpage>
<pub-id pub-id-type="doi">10.1007/s00726-015-2032-z</pub-id>
<pub-id pub-id-type="pmid">26123990</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braissant</surname>
<given-names>O</given-names>
</name>
<name>
<surname>McLin</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Cudalbu</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Ammonia toxicity to the brain</article-title>
<source/>J Inherit Metab Dis
          <year>2013</year>
<volume>36</volume>
<issue>4</issue>
<fpage>595</fpage>
<lpage>612</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-012-9546-2</pub-id>
<pub-id pub-id-type="pmid">23109059</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bigot</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brunault</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lavigne</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Feillet</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Odent</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kaphan</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Psychiatric adult-onset of urea cycle disorders: A case-series</article-title>
<source/>Mol Genet Metab Rep
          <year>2017</year>
<volume>12</volume>
<fpage>103</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymgmr.2017.07.001</pub-id>
<pub-id pub-id-type="pmid">28725569</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laemmle</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Keogh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stricker</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gautschi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nuoffer</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Frequency and pathophysiology of acute liver failure in ornithine Transcarbamylase deficiency (OTCD)</article-title>
<source/>PLoS One
          <year>2016</year>
<volume>11</volume>
<issue>4</issue>
<fpage>e0153358</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0153358</pub-id>
<pub-id pub-id-type="pmid">27070778</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<mixed-citation publication-type="other">British Inherited Metabolic Disease Group. Adult emergency management urea cycle defects 2012. Available from: <ext-link ext-link-type="uri" xlink:href="http://bimdg.org.uk/store/guidelines/ADULT_UCD-rev_2015_422170_09012016.pdf">http://bimdg.org.uk/store/guidelines/ADULT_UCD-rev_2015_422170_09012016.pdf</ext-link>. Accessed 18 March 2018.</mixed-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arn</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Hauser</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Herman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Brusilow</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus. A cause of postpartum coma</article-title>
<source/>N Engl J Med
          <year>1990</year>
<volume>322</volume>
<issue>23</issue>
<fpage>1652</fpage>
<lpage>1655</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199006073222307</pub-id>
<pub-id pub-id-type="pmid">2342525</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<mixed-citation publication-type="other">Lamb S, Aye CY, Murphy E, Mackillop L. Multidisciplinary management of ornithine transcarbamylase (OTC) deficiency in pregnancy: Essential to prevent hyperammonemic complications. BMJ Case Rep. 2013;2013</mixed-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lipskind</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Loanzon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Simi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids</article-title>
<source/>J Perinatol
          <year>2011</year>
<volume>31</volume>
<issue>10</issue>
<fpage>682</fpage>
<lpage>684</lpage>
<pub-id pub-id-type="doi">10.1038/jp.2011.23</pub-id>
<pub-id pub-id-type="pmid">21956151</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crosbie</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Sugumar</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Dewey</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Reade</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Late-onset ornithine transcarbamylase deficiency: A potentially fatal yet treatable cause of coma</article-title>
<source/>Crit Care Resusc
          <year>2009</year>
<volume>11</volume>
<issue>3</issue>
<fpage>222</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="pmid">19737127</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maestri</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Lord</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Glynn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bale</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brusilow</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency</article-title>
<source/>Medicine (Baltimore)
          <year>1998</year>
<volume>77</volume>
<issue>6</issue>
<fpage>389</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="doi">10.1097/00005792-199811000-00004</pub-id>
<pub-id pub-id-type="pmid">9854602</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mendez-Figueroa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lamance</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sutton</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Aagaard-Tillery</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Van den Veyver</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Management of ornithine transcarbamylase deficiency in pregnancy</article-title>
<source/>Am J Perinatol
          <year>2010</year>
<volume>27</volume>
<issue>10</issue>
<fpage>775</fpage>
<lpage>784</lpage>
<pub-id pub-id-type="doi">10.1055/s-0030-1254240</pub-id>
<pub-id pub-id-type="pmid">20458665</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schimanski</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Krieger</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Horn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stremmel</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wermuth</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Theilmann</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>A novel two-nucleotide deletion in the ornithine transcarbamylase gene causing fatal hyperammonia in early pregnancy</article-title>
<source/>Hepatology
          <year>1996</year>
<volume>24</volume>
<issue>6</issue>
<fpage>1413</fpage>
<lpage>1415</lpage>
<pub-id pub-id-type="doi">10.1002/hep.510240618</pub-id>
<pub-id pub-id-type="pmid">8938172</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celik</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Buyuktas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Aydin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Acbay</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Ornithine transcarbamylase deficiency diagnosed in pregnancy</article-title>
<source/>Gynecol Endocrinol
          <year>2011</year>
<volume>27</volume>
<issue>12</issue>
<fpage>1052</fpage>
<lpage>1054</lpage>
<pub-id pub-id-type="doi">10.3109/09513590.2011.569787</pub-id>
<pub-id pub-id-type="pmid">21736537</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cordero</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dorinzi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Toffle</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Ornithine transcarbamylase deficiency in pregnancy</article-title>
<source/>J Inherit Metab Dis
          <year>2005</year>
<volume>28</volume>
<issue>2</issue>
<fpage>237</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-005-5514-4</pub-id>
<pub-id pub-id-type="pmid">15877212</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Redonnet-Vernhet</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Rouanet</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pedespan</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Hocke</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Parrot</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>A successful pregnancy in a heterozygote for OTC deficiency treated with sodium phenylbutyrate</article-title>
<source/>Neurology
          <year>2000</year>
<volume>54</volume>
<issue>4</issue>
<fpage>1008</fpage>
<pub-id pub-id-type="doi">10.1212/WNL.54.4.1008</pub-id>
<pub-id pub-id-type="pmid">10691008</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bailly</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Noury</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Timsit</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ben</surname>
<given-names>SD</given-names>
</name>
</person-group>
<article-title>Teaching NeuroImages: Ornithine transcarbamylase deficiency revealed by a coma in a pregnant woman</article-title>
<source/>Neurology
          <year>2015</year>
<volume>85</volume>
<issue>20</issue>
<fpage>e146</fpage>
<lpage>e147</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000002131</pub-id>
<pub-id pub-id-type="pmid">26574542</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsuchiyama</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Aoyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Oyanagi</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Secondary carnitine deficiency in the newborn period in twins of a mother with partial ornithine transcarbamylase deficiency</article-title>
<source/>J Pediatr
          <year>1989</year>
<volume>115</volume>
<issue>4</issue>
<fpage>611</fpage>
<lpage>614</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(89)80296-3</pub-id>
<pub-id pub-id-type="pmid">2795359</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Legras</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Labarthe</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Maillot</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Garrigue</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Kouatchet</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Ogier de Baulny H. Late diagnosis of ornithine transcarbamylase defect in three related female patients: Polymorphic presentations</article-title>
<source/>Crit Care Med
          <year>2002</year>
<volume>30</volume>
<issue>1</issue>
<fpage>241</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1097/00003246-200201000-00035</pub-id>
<pub-id pub-id-type="pmid">11902270</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterson</surname>
<given-names>DE</given-names>
</name>
</person-group>
<article-title>Acute postpartum mental status change and coma caused by previously undiagnosed ornithine transcarbamylase deficiency</article-title>
<source/>Obstet Gynecol
          <year>2003</year>
<volume>102</volume>
<issue>5 Pt 2</issue>
<fpage>1212</fpage>
<lpage>1215</lpage>
<pub-id pub-id-type="pmid">14607061</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tihtonen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Uotila</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lahde</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Salo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Keskinen</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Risk of hyperammonemic coma in the puerperium: Two cases of women with diagnosed and undiagnosed deficiency of urea cycle enzymes</article-title>
<source/>Acta Obstet Gynecol Scand
          <year>2010</year>
<volume>89</volume>
<issue>3</issue>
<fpage>404</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="doi">10.3109/00016340903540646</pub-id>
<pub-id pub-id-type="pmid">20102292</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ituk</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Constantinescu</surname>
<given-names>OC</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Small</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Habib</surname>
<given-names>AS</given-names>
</name>
</person-group>
<article-title>Peripartum management of two parturients with ornithine transcarbamylase deficiency</article-title>
<source/>Int J Obstet Anesth
          <year>2012</year>
<volume>21</volume>
<issue>1</issue>
<fpage>90</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijoa.2011.09.007</pub-id>
<pub-id pub-id-type="pmid">22138526</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinclair</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ket</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Testro</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gow</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Angus</surname>
<given-names>PW</given-names>
</name>
</person-group>
<article-title>Acute hepatic decompensation precipitated by pregnancy-related catabolic stress: A rare mimic of acute liver failure</article-title>
<source/>Obstet Gynecol
          <year>2014</year>
<volume>123</volume>
<issue>2 Pt 2 Suppl 2</issue>
<fpage>480</fpage>
<lpage>483</lpage>
<pub-id pub-id-type="doi">10.1097/AOG.000000000000005</pub-id>
<pub-id pub-id-type="pmid">24413235</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salek</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Byrne</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Box</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Longo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sussman</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Recurrent liver failure in a 25-year-old female</article-title>
<source/>Liver Transpl
          <year>2010</year>
<volume>16</volume>
<issue>9</issue>
<fpage>1049</fpage>
<lpage>1053</lpage>
<pub-id pub-id-type="doi">10.1002/lt.22118</pub-id>
<pub-id pub-id-type="pmid">20818742</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tonini</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Bignamini</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mattioli</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Headache and neuropsychic disorders in the puerperium: A case report with suspected deficiency of urea cycle enzymes</article-title>
<source/>Neurol Sci
          <year>2011</year>
<volume>32</volume>
<issue>Suppl 1</issue>
<fpage>S157</fpage>
<lpage>S159</lpage>
<pub-id pub-id-type="doi">10.1007/s10072-011-0518-3</pub-id>
<pub-id pub-id-type="pmid">21533735</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Enns</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>O'Brien</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shinzawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pellegrino</surname>
<given-names>JE</given-names>
</name>
</person-group>
<article-title>Postpartum "psychosis" in mild argininosuccinate synthetase deficiency</article-title>
<source/>Obstet Gynecol
          <year>2005</year>
<volume>105</volume>
<issue>5 Pt 2</issue>
<fpage>1244</fpage>
<lpage>1246</lpage>
<pub-id pub-id-type="doi">10.1097/01.AOG.0000157769.90230.24</pub-id>
<pub-id pub-id-type="pmid">15863597</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kurasawa</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Furuta</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ishihara</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A pregnant patient with fulminant hepatic failure was found to carry a novel missense mutation in the argininosuccinate synthetase gene</article-title>
<source/>J Gastroenterol
          <year>2004</year>
<volume>39</volume>
<issue>11</issue>
<fpage>1115</fpage>
<lpage>1117</lpage>
<pub-id pub-id-type="doi">10.1007/s00535-004-1455-1</pub-id>
<pub-id pub-id-type="pmid">15580409</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Potter</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Zeesman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>HZ</given-names>
</name>
<name>
<surname>Tabata</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pregnancy in a healthy woman with untreated citrullinemia</article-title>
<source/>Am J Med Genet A
          <year>2004</year>
<volume>129a</volume>
<issue>1</issue>
<fpage>77</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.20559</pub-id>
<pub-id pub-id-type="pmid">15266621</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reid</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Perreault</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lafrance</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>JT</given-names>
</name>
</person-group>
<article-title>Experience with the treatment of argininosuccinic aciduria during pregnancy</article-title>
<source/>J Inherit Metab Dis
          <year>2009</year>
<volume>32</volume>
<issue>Suppl 1</issue>
<fpage>S191</fpage>
<lpage>S195</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-009-1145-5</pub-id>
<pub-id pub-id-type="pmid">19585269</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mardach</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Roe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cederbaum</surname>
<given-names>SD</given-names>
</name>
</person-group>
<article-title>Successful pregnancy outcome in a woman with argininosuccinate lyase deficiency</article-title>
<source/>J Inherit Metab Dis
          <year>1999</year>
<volume>22</volume>
<issue>2</issue>
<fpage>102</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="doi">10.1023/A:1005481431955</pub-id>
<pub-id pub-id-type="pmid">10234604</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Worthington</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wilcken</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Peat</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Pregnancy and argininosuccinic aciduria</article-title>
<source/>J Inherit Metab Dis
          <year>1996</year>
<volume>19</volume>
<issue>5</issue>
<fpage>621</fpage>
<lpage>623</lpage>
<pub-id pub-id-type="doi">10.1007/BF01799836</pub-id>
<pub-id pub-id-type="pmid">8892017</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eather</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Coman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lander</surname>
<given-names>C</given-names>
</name>
<name>
<surname>McGill</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Carbamyl phosphate synthase deficiency: Diagnosed during pregnancy in a 41-year-old</article-title>
<source/>J Clin Neurosci
          <year>2006</year>
<volume>13</volume>
<issue>6</issue>
<fpage>702</fpage>
<lpage>706</lpage>
<pub-id pub-id-type="doi">10.1016/j.jocn.2005.07.014</pub-id>
<pub-id pub-id-type="pmid">16860720</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanner</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nanto-Salonen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Niinikoski</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Erkkola</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Huoponen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Simell</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Hazards associated with pregnancies and deliveries in lysinuric protein intolerance</article-title>
<source/>Metabolism
          <year>2006</year>
<volume>55</volume>
<issue>2</issue>
<fpage>224</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1016/j.metabol.2005.08.016</pub-id>
<pub-id pub-id-type="pmid">16423630</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osada</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Seki</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Amino acid changes during successful pregnancy in a case of lysinuric protein insufficiency</article-title>
<source/>Gynecol Obstet Investig
          <year>2006</year>
<volume>61</volume>
<issue>3</issue>
<fpage>139</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="doi">10.1159/000090410</pub-id>
<pub-id pub-id-type="pmid">16374016</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikolajek-Bedner</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Torbe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kwiatkowski</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Michalczyk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gizewska</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rokicki</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pregnancy delivery and puerperium in a patient with lysinuric protein intolerance--a case report</article-title>
<source/>Ginekol Pol
          <year>2013</year>
<volume>84</volume>
<issue>7</issue>
<fpage>654</fpage>
<lpage>656</lpage>
<pub-id pub-id-type="pmid">24032281</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname>
<given-names>FL</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Snodgrass</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Huffman</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>PG</given-names>
</name>
</person-group>
<article-title>Abnormalities of hepatic mitochondrial urea-cycle enzyme activities and hepatic ultrastructure in acute fatty liver of pregnancy</article-title>
<source/>J Lab Clin Med
          <year>1979</year>
<volume>94</volume>
<issue>1</issue>
<fpage>27</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">469376</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fassier</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Guffon</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Acquaviva</surname>
<given-names>C</given-names>
</name>
<name>
<surname>D'Amato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Durand</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Domenech</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Misdiagnosed postpartum psychosis revealing a late-onset urea cycle disorder</article-title>
<source/>Am J Psychiatry
          <year>2011</year>
<volume>168</volume>
<issue>6</issue>
<fpage>576</fpage>
<lpage>580</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2010.10071032</pub-id>
<pub-id pub-id-type="pmid">21642480</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<mixed-citation publication-type="other">Weiss N, Mochel F, Rudler M, Demeret S, Lebray P, Conti F, et al. Peak hyperammonemia and atypical acute liver failure: The eruption of an urea cycle disorder during hyperemesis gravidarum. J Hepatol. 2017;</mixed-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>London</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Grube</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sherer</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Abulafia</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Hyperemesis Gravidarum: A review of recent literature</article-title>
<source/>Pharmacology
          <year>2017</year>
<volume>100</volume>
<issue>3–4</issue>
<fpage>161</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1159/000477853</pub-id>
<pub-id pub-id-type="pmid">28641304</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Wegberg</surname>
<given-names>AMJ</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ahring</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Belanger-Quintana</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Blau</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bosch</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The complete European guidelines on phenylketonuria: Diagnosis and treatment</article-title>
<source/>Orphanet J Rare Dis
          <year>2017</year>
<volume>12</volume>
<issue>1</issue>
<fpage>162</fpage>
<pub-id pub-id-type="doi">10.1186/s13023-017-0685-2</pub-id>
<pub-id pub-id-type="pmid">29025426</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Spronsen</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>van Wegberg</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Ahring</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Belanger-Quintana</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Blau</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bosch</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Key European guidelines for the diagnosis and management of patients with phenylketonuria</article-title>
<source/>Lancet Diabetes Endocrinol
          <year>2017</year>
<volume>5</volume>
<issue>9</issue>
<fpage>743</fpage>
<lpage>756</lpage>
<pub-id pub-id-type="doi">10.1016/S2213-8587(16)30320-5</pub-id>
<pub-id pub-id-type="pmid">28082082</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<mixed-citation publication-type="other">Kumru B, Kaplan DS, Ozturk Hismi B, Celik H. Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients. Cell Mol Neurobiol. 2017.</mixed-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roato</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Porta</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mussa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>D'Amico</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fiore</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Garelli</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase</article-title>
<source/>PLoS One
          <year>2010</year>
<volume>5</volume>
<issue>11</issue>
<fpage>e14167</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0014167</pub-id>
<pub-id pub-id-type="pmid">21152388</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yildiz</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Dursun</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tokatli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Coskun</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sivri</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Partial hydatidiform mole in a phenylketonuria patient treated with sapropterin dihydrochloride</article-title>
<source/>Gynecol Endocrinol
          <year>2017</year>
<volume>33</volume>
<issue>1</issue>
<fpage>19</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1080/09513590.2016.1247796</pub-id>
<pub-id pub-id-type="pmid">27898272</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grange</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Hillman</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Burton</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Yano</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vockley</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fong</surname>
<given-names>CT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sapropterin dihydrochloride use in pregnant women with phenylketonuria: An interim report of the PKU MOMS sub-registry</article-title>
<source/>Mol Genet Metab
          <year>2014</year>
<volume>112</volume>
<issue>1</issue>
<fpage>9</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymgme.2014.02.016</pub-id>
<pub-id pub-id-type="pmid">24667082</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feillet</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Muntau</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Debray</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Lotz-Havla</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Puchwein-Schwepcke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fofou-Caillierez</surname>
<given-names>MB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Use of sapropterin dihydrochloride in maternal phenylketonuria. A European experience of eight cases</article-title>
<source/>J Inherit Metab Dis
          <year>2014</year>
<volume>37</volume>
<issue>5</issue>
<fpage>753</fpage>
<lpage>762</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-014-9716-5</pub-id>
<pub-id pub-id-type="pmid">24789341</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mabry</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Denniston</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>CD</given-names>
</name>
</person-group>
<article-title>Maternal Phenylketonuria. A cause of mental retardation in children without the metabolic defect</article-title>
<source/>N Engl J Med
          <year>1963</year>
<volume>269</volume>
<fpage>1404</fpage>
<lpage>1408</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM196312262692604</pub-id>
<pub-id pub-id-type="pmid">14064329</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levy</surname>
<given-names>HL</given-names>
</name>
</person-group>
<article-title>Historical background for the maternal PKU syndrome</article-title>
<source/>Pediatrics
          <year>2003</year>
<volume>112</volume>
<issue>6 Pt 2</issue>
<fpage>1516</fpage>
<lpage>1518</lpage>
<pub-id pub-id-type="pmid">14654656</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lenke</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>HL</given-names>
</name>
</person-group>
<article-title>Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies</article-title>
<source/>N Engl J Med
          <year>1980</year>
<volume>303</volume>
<issue>21</issue>
<fpage>1202</fpage>
<lpage>1208</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM198011203032104</pub-id>
<pub-id pub-id-type="pmid">7421947</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prick</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Hop</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Duvekot</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Maternal phenylketonuria and hyperphenylalaninemia in pregnancy: Pregnancy complications and neonatal sequelae in untreated and treated pregnancies</article-title>
<source/>Am J Clin Nutr
          <year>2012</year>
<volume>95</volume>
<issue>2</issue>
<fpage>374</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.3945/ajcn.110.009456</pub-id>
<pub-id pub-id-type="pmid">22205310</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohlschutter</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ellerbrok</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Merkel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tchirikov</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zschocke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Santer</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phenylalanine tolerance in three phenylketonuric women pregnant with fetuses of different genetic PKU status</article-title>
<source/>J Inherit Metab Dis
          <year>2009</year>
<volume>32</volume>
<issue>Suppl 1</issue>
<fpage>S1</fpage>
<lpage>S4</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-008-0910-1</pub-id>
<pub-id pub-id-type="pmid">19194782</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<mixed-citation publication-type="other">Sacharow SJ, Picker JD, Levy HL. Homocystinuria caused by cystathionine Beta-synthase deficiency. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, bean LJH, Stephens K, et al., editors. GeneReviews((R)). Seattle (WA): University of Washington, Seattle University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993.</mixed-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Kozich</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Santra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Andria</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ben-Omran</surname>
<given-names>TI</given-names>
</name>
<name>
<surname>Chakrapani</surname>
<given-names>AB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency</article-title>
<source/>J Inherit Metab Dis
          <year>2017</year>
<volume>40</volume>
<issue>1</issue>
<fpage>49</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-016-9979-0</pub-id>
<pub-id pub-id-type="pmid">27778219</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<mixed-citation publication-type="other">Dean L. Methylenetetrahydrofolate Reductase Deficiency. In: Pratt V, McLeod H, Dean L, Malheiro A, Rubinstein W, editors. Medical Genetics Summaries. Bethesda (MD): National Center for Biotechnology Information (US); 2012.</mixed-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carrillo-Carrasco</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chandler</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Venditti</surname>
<given-names>CP</given-names>
</name>
</person-group>
<article-title>Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management</article-title>
<source/>J Inherit Metab Dis
          <year>2012</year>
<volume>35</volume>
<issue>1</issue>
<fpage>91</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-011-9364-y</pub-id>
<pub-id pub-id-type="pmid">21748409</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levy</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Vargas</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Waisbren</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Kurczynski</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Roeder</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>RS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reproductive fitness in maternal homocystinuria due to cystathionine beta-synthase deficiency</article-title>
<source/>J Inherit Metab Dis
          <year>2002</year>
<volume>25</volume>
<issue>4</issue>
<fpage>299</fpage>
<lpage>314</lpage>
<pub-id pub-id-type="doi">10.1023/A:1016502408305</pub-id>
<pub-id pub-id-type="pmid">12227460</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<mixed-citation publication-type="other">Novy J, Ballhausen D, Bonafe L, Cairoli A, Angelillo-Scherrer A, Bachmann C, et al. Recurrent postpartum cerebral sinus vein thrombosis as a presentation of cystathionine-beta-synthase deficiency. Thromb Haemost. 103. Germany 2010. p. 871–873.</mixed-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fekih-Mrissa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>El Housaini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kaabechi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nsiri</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rachdi</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of MTHFR A1298C polymorphism (but not of MTHFR C677T) with elevated homocysteine levels and placental vasculopathies</article-title>
<source/>Blood Coagul Fibrinolysis
          <year>2011</year>
<volume>22</volume>
<issue>5</issue>
<fpage>374</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="doi">10.1097/MBC.0b013e328344f80f</pub-id>
<pub-id pub-id-type="pmid">21577095</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Unfried</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Griesmacher</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Weismuller</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Nagele</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Tempfer</surname>
<given-names>CB</given-names>
</name>
</person-group>
<article-title>The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage</article-title>
<source/>Obstet Gynecol
          <year>2002</year>
<volume>99</volume>
<issue>4</issue>
<fpage>614</fpage>
<lpage>619</lpage>
<pub-id pub-id-type="pmid">12039122</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nowak</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bylinska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wilczynska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wisniewski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Malinowski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wilczynski</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The methylenetetrahydrofolate reductase c.c.677 C&gt;T and c.c.1298 A&gt;C polymorphisms in reproductive failures: Experience from an RSA and RIF study on a Polish population</article-title>
<source/>PLoS One
          <year>2017</year>
<volume>12</volume>
<issue>10</issue>
<fpage>e0186022</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0186022</pub-id>
<pub-id pub-id-type="pmid">29073227</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nursal</surname>
<given-names>Ayse Feyda</given-names>
</name>
<name>
<surname>Kaya</surname>
<given-names>Süheyla</given-names>
</name>
<name>
<surname>Sezer</surname>
<given-names>Ozlem</given-names>
</name>
<name>
<surname>Karakus</surname>
<given-names>Nevin</given-names>
</name>
<name>
<surname>Yigit</surname>
<given-names>Serbulent</given-names>
</name>
</person-group>
<article-title>MTHFR gene C677T and A1298C variants are associated with FMF risk in a Turkish cohort</article-title>
<source/>Journal of Clinical Laboratory Analysis
          <year>2017</year>
<volume>32</volume>
<issue>2</issue>
<fpage>e22259</fpage>
<pub-id pub-id-type="doi">10.1002/jcla.22259</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Paik</surname>
<given-names>EC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Methylenetetrahydrofolate reductase polymorphisms and risk of recurrent pregnancy loss: A case-control study</article-title>
<source/>J Korean Med Sci
          <year>2017</year>
<volume>32</volume>
<issue>12</issue>
<fpage>2029</fpage>
<lpage>2034</lpage>
<pub-id pub-id-type="doi">10.3346/jkms.2017.32.12.2029</pub-id>
<pub-id pub-id-type="pmid">29115087</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Achkar</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wafa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ammar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moassass</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Jarjour</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Association of methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms with recurrent pregnancy loss in Syrian women</article-title>
<source/>Reprod Sci
          <year>2017</year>
<volume>24</volume>
<issue>9</issue>
<fpage>1275</fpage>
<lpage>1279</lpage>
<pub-id pub-id-type="doi">10.1177/1933719116682874</pub-id>
<pub-id pub-id-type="pmid">28814189</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pacchiarotti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Micara</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Linari</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tranquilli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Espinola</surname>
<given-names>SB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The possible role of hyperhomocysteinemia on IVF outcome</article-title>
<source/>J Assist Reprod Genet
          <year>2007</year>
<volume>24</volume>
<issue>10</issue>
<fpage>459</fpage>
<lpage>462</lpage>
<pub-id pub-id-type="doi">10.1007/s10815-007-9165-2</pub-id>
<pub-id pub-id-type="pmid">17763935</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Ogier de Baulny</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dionisi-Vici</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wendel</surname>
<given-names>U</given-names>
</name>
</person-group>
<source/>Branched Chain Organic Acidurias/Acidaemias. 5th ed. Heidelberg
          <year>2012</year>
<publisher-loc>New York</publisher-loc>
<publisher-name>Springer-Verlag</publisher-name>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<mixed-citation publication-type="other">Strauss KA, Puffenberger EG, Morton DH. Maple syrup urine disease. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, bean LJH, Stephens K, et al., editors. GeneReviews((R)). Seattle (WA): University of Washington, Seattle University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993.</mixed-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<mixed-citation publication-type="other">Salway J. Metabolism at a Glance. 4th ed: Wiley-Blackwell; 2017. p. 90–1.</mixed-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blackburn</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Gass</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Vairo</surname>
<given-names>FPE</given-names>
</name>
<name>
<surname>Farnham</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Atwal</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Macklin</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maple syrup urine disease: Mechanisms and management</article-title>
<source/>Appl Clin Genet
          <year>2017</year>
<volume>10</volume>
<fpage>57</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.2147/TACG.S125962</pub-id>
<pub-id pub-id-type="pmid">28919799</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muelly</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Bunce</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Mack</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bigler</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Morton</surname>
<given-names>DH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Biochemical correlates of neuropsychiatric illness in maple syrup urine disease</article-title>
<source/>J Clin Invest
          <year>2013</year>
<volume>123</volume>
<issue>4</issue>
<fpage>1809</fpage>
<lpage>1820</lpage>
<pub-id pub-id-type="doi">10.1172/JCI67217</pub-id>
<pub-id pub-id-type="pmid">23478409</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Podebrad</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Heil</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Reichert</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mosandl</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sewell</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Bohles</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>4,5-dimethyl-3-hydroxy-2[5H]-furanone (sotolone)--the odour of maple syrup urine disease</article-title>
<source/>J Inherit Metab Dis
          <year>1999</year>
<volume>22</volume>
<issue>2</issue>
<fpage>107</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="doi">10.1023/A:1005433516026</pub-id>
<pub-id pub-id-type="pmid">10234605</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Baulny</surname>
<given-names>Hélène Ogier de</given-names>
</name>
<name>
<surname>Dionisi-Vici</surname>
<given-names>Carlo</given-names>
</name>
<name>
<surname>Wendel</surname>
<given-names>Udo</given-names>
</name>
</person-group>
<article-title>Branched-chain Organic Acidurias/Acidaemias</article-title>
<source/>Inborn Metabolic Diseases
          <year>2012</year>
<publisher-loc>Berlin, Heidelberg</publisher-loc>
<publisher-name>Springer Berlin Heidelberg</publisher-name>
<fpage>277</fpage>
<lpage>296</lpage>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Postpartum death with maple syrup urine disease</article-title>
<source/>Int J Gynaecol Obstet
          <year>2003</year>
<volume>81</volume>
<issue>1</issue>
<fpage>57</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1016/S0020-7292(02)00446-0</pub-id>
<pub-id pub-id-type="pmid">12676398</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Calcar</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>CO</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Barness</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Wolff</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Case reports of successful pregnancy in women with maple syrup urine disease and propionic acidemia</article-title>
<source/>Am J Med Genet
          <year>1992</year>
<volume>44</volume>
<issue>5</issue>
<fpage>641</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.1320440523</pub-id>
<pub-id pub-id-type="pmid">1481826</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grunewald</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hinrichs</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wendel</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Pregnancy in a woman with maple syrup urine disease</article-title>
<source/>J Inherit Metab Dis
          <year>1998</year>
<volume>21</volume>
<issue>2</issue>
<fpage>89</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1023/A:1005396823030</pub-id>
<pub-id pub-id-type="pmid">9584259</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tchan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Westbrook</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wilcox</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cutler</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Penman</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The management of pregnancy in maple syrup urine disease: Experience with two patients</article-title>
<source/>JIMD Rep
          <year>2013</year>
<volume>10</volume>
<fpage>113</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="doi">10.1007/8904_2013_212</pub-id>
<pub-id pub-id-type="pmid">23430812</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wessel</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Mogensen</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Rohr</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Erick</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Neilan</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Chopra</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Management of a Woman with Maple Syrup Urine Disease during Pregnancy, delivery, and lactation</article-title>
<source/>JPEN J Parenter Enteral Nutr
          <year>2015</year>
<volume>39</volume>
<issue>7</issue>
<fpage>875</fpage>
<lpage>879</lpage>
<pub-id pub-id-type="doi">10.1177/0148607114526451</pub-id>
<pub-id pub-id-type="pmid">24618664</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mello</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Feksa</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Brusque</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Wannmacher</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Wajner</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Chronic early leucine administration induces behavioral deficits in rats</article-title>
<source/>Life Sci
          <year>1999</year>
<volume>65</volume>
<issue>8</issue>
<fpage>747</fpage>
<lpage>755</lpage>
<pub-id pub-id-type="doi">10.1016/S0024-3205(99)00301-X</pub-id>
<pub-id pub-id-type="pmid">10466740</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<mixed-citation publication-type="other">Tuncel AT, Boy N, Morath MA, Horster F, Mutze U, Kolker S. Organic acidurias in adults: Late complications and management. J Inherit Metab Dis. 2018;</mixed-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wajner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>SI</given-names>
</name>
</person-group>
<article-title>Disruption of mitochondrial homeostasis in organic acidurias: Insights from human and animal studies</article-title>
<source/>J Bioenerg Biomembr
          <year>2011</year>
<volume>43</volume>
<issue>1</issue>
<fpage>31</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1007/s10863-011-9324-0</pub-id>
<pub-id pub-id-type="pmid">21249436</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heringer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Valayannopoulos</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Wijburg</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Freisinger</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Baric</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impact of age at onset and newborn screening on outcome in organic acidurias</article-title>
<source/>J Inherit Metab Dis
          <year>2016</year>
<volume>39</volume>
<issue>3</issue>
<fpage>341</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-015-9907-8</pub-id>
<pub-id pub-id-type="pmid">26689403</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baumgartner</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Horster</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dionisi-Vici</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Haliloglu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Karall</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>KA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia</article-title>
<source/>Orphanet J Rare Dis
          <year>2014</year>
<volume>9</volume>
<fpage>130</fpage>
<pub-id pub-id-type="doi">10.1186/s13023-014-0130-8</pub-id>
<pub-id pub-id-type="pmid">25205257</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spinty</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rogozinski</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lealman</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Wraith</surname>
<given-names>JE</given-names>
</name>
</person-group>
<article-title>Second case of a successful pregnancy in maternal isovaleric acidaemia</article-title>
<source/>J Inherit Metab Dis
          <year>2002</year>
<volume>25</volume>
<issue>8</issue>
<fpage>697</fpage>
<lpage>698</lpage>
<pub-id pub-id-type="doi">10.1023/A:1022837416232</pub-id>
<pub-id pub-id-type="pmid">12705500</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shih</surname>
<given-names>VE</given-names>
</name>
<name>
<surname>Aubry</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>DeGrande</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gursky</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Maternal isovaleric acidemia</article-title>
<source/>J Pediatr
          <year>1984</year>
<volume>105</volume>
<issue>1</issue>
<fpage>77</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(84)80367-4</pub-id>
<pub-id pub-id-type="pmid">6547481</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castelnovi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Moseley</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yano</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Maternal isovaleric acidemia: Observation of distinctive changes in plasma amino acids and carnitine profiles during pregnancy</article-title>
<source/>Clin Chim Acta
          <year>2010</year>
<volume>411</volume>
<issue>23–24</issue>
<fpage>2101</fpage>
<lpage>2103</lpage>
<pub-id pub-id-type="doi">10.1016/j.cca.2010.08.023</pub-id>
<pub-id pub-id-type="pmid">20807522</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Habets</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Schaper</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Rogozinski</surname>
<given-names>H</given-names>
</name>
<name>
<surname>van Spronsen</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>van Rijn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bierau</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Biochemical monitoring and management during pregnancy in patients with Isovaleric Acidaemia is helpful to prevent metabolic decompensation</article-title>
<source/>JIMD Rep
          <year>2012</year>
<volume>3</volume>
<fpage>83</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1007/8904_2011_66</pub-id>
<pub-id pub-id-type="pmid">23430878</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scott Schwoerer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van Calcar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Deline</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Successful pregnancy and delivery in a woman with propionic acidemia from the Amish community</article-title>
<source/>Mol Genet Metab Rep
          <year>2016</year>
<volume>8</volume>
<fpage>4</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymgmr.2016.05.003</pub-id>
<pub-id pub-id-type="pmid">28649556</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mungan</surname>
<given-names>NO</given-names>
</name>
<name>
<surname>Kor</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Buyukkurt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Atmis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gulec</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Satar</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Propionic acidemia: A Turkish case report of a successful pregnancy, labor and lactation</article-title>
<source/>J Pediatr Endocrinol Metab
          <year>2016</year>
<volume>29</volume>
<issue>7</issue>
<fpage>863</fpage>
<lpage>866</lpage>
<pub-id pub-id-type="doi">10.1515/jpem-2015-0451</pub-id>
<pub-id pub-id-type="pmid">27089410</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raval</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Merideth</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sloan</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Braverman</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Conway</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Manoli</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Methylmalonic acidemia (MMA) in pregnancy: A case series and literature review</article-title>
<source/>J Inherit Metab Dis
          <year>2015</year>
<volume>38</volume>
<issue>5</issue>
<fpage>839</fpage>
<lpage>846</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-014-9802-8</pub-id>
<pub-id pub-id-type="pmid">25567501</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<mixed-citation publication-type="other">Jacquemyn Y, Den Hartog M, Eyskens F. Methylmalonic acidaemia in pregnancy. BMJ Case Rep 2014;2014.</mixed-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pipitone</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Raval</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Duis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vernon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hamosh</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The management of pregnancy and delivery in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency</article-title>
<source/>Am J Med Genet A
          <year>2016</year>
<volume>170</volume>
<issue>6</issue>
<fpage>1600</fpage>
<lpage>1602</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.37620</pub-id>
<pub-id pub-id-type="pmid">26997609</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lubrano</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bellelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gentile</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Paoli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Carducci</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Santagata</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pregnancy in a methylmalonic acidemia patient with kidney transplantation: a case report</article-title>
<source/>Am J Transplant
          <year>2013</year>
<volume>13</volume>
<issue>7</issue>
<fpage>1918</fpage>
<lpage>1922</lpage>
<pub-id pub-id-type="doi">10.1111/ajt.12282</pub-id>
<pub-id pub-id-type="pmid">23711287</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wasserstein</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Gaddipati</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Snyderman</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Eddleman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Desnick</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Sansaricq</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Successful pregnancy in severe methylmalonic acidaemia</article-title>
<source/>J Inherit Metab Dis
          <year>1999</year>
<volume>22</volume>
<issue>7</issue>
<fpage>788</fpage>
<lpage>794</lpage>
<pub-id pub-id-type="doi">10.1023/A:1005597722237</pub-id>
<pub-id pub-id-type="pmid">10518278</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>First Chinese case of successful pregnancy with combined methylmalonic aciduria and homocystinuria, cblC type</article-title>
<source/>Brain and Development
          <year>2015</year>
<volume>37</volume>
<issue>3</issue>
<fpage>286</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1016/j.braindev.2014.06.007</pub-id>
<pub-id pub-id-type="pmid">24974159</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brunel-Guitton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Treatment of cobalamin C (cblC) deficiency during pregnancy</article-title>
<source/>J Inherit Metab Dis
          <year>2010</year>
<volume>33</volume>
<issue>Suppl 3</issue>
<fpage>S409</fpage>
<lpage>S412</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-010-9202-7</pub-id>
<pub-id pub-id-type="pmid">20830523</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viau</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ernst</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Vanzo</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Botto</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Pasquali</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Longo</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Glutaric acidemia type 1: Outcomes before and after expanded newborn screening</article-title>
<source/>Mol Genet Metab
          <year>2012</year>
<volume>106</volume>
<issue>4</issue>
<fpage>430</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymgme.2012.05.024</pub-id>
<pub-id pub-id-type="pmid">22728054</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ituk</surname>
<given-names>US</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Habib</surname>
<given-names>AS</given-names>
</name>
</person-group>
<article-title>The peripartum management of a patient with glutaric aciduria type 1</article-title>
<source/>J Clin Anesth
          <year>2013</year>
<volume>25</volume>
<issue>2</issue>
<fpage>141</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="doi">10.1016/j.jclinane.2012.06.023</pub-id>
<pub-id pub-id-type="pmid">23352788</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<label>130.</label>
<mixed-citation publication-type="other">Stepien KM, Pastores GM, Hendroff U, McCormick C, Fitzimons P, Khawaja N, et al. Two uneventful pregnancies in a woman with Glutaric aciduria type 1. JIMD Rep. 2018;</mixed-citation>
</ref>
<ref id="CR131">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Martins</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Diogo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Marcao</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gaspar</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Outcome of three cases of untreated maternal glutaric aciduria type I</article-title>
<source/>Eur J Pediatr
          <year>2008</year>
<volume>167</volume>
<issue>5</issue>
<fpage>569</fpage>
<lpage>573</lpage>
<pub-id pub-id-type="doi">10.1007/s00431-007-0556-2</pub-id>
<pub-id pub-id-type="pmid">17661081</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Smit</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Schoser</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Glycogen storage diseases of all types</article-title>
<source/>J Inherit Metab Dis
          <year>2015</year>
<volume>38</volume>
<issue>3</issue>
<fpage>389</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-015-9848-2</pub-id>
<pub-id pub-id-type="pmid">25940909</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<label>133.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Walter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Labrune</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Laforet</surname>
<given-names>P</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Saudhubray</surname>
<given-names>J-M</given-names>
</name>
<name>
<surname>Baumgartner</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>The glycogen storage diseases and related disorders</article-title>
<source/>Inborn metabolic diseases diagnosis and treatment
          <year>2016</year>
<edition>6</edition>
<publisher-loc>Heidelberg New York</publisher-loc>
<publisher-name>Springer</publisher-name>
<fpage>121</fpage>
<lpage>135</lpage>
</element-citation>
</ref>
<ref id="CR134">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilcox</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Stepien</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Hendriksz</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Strauss</surname>
<given-names>BJG</given-names>
</name>
</person-group>
<article-title>Anthropometric and metabolic indices in adults with glycogen storage disease types I, III &amp; IX</article-title>
<source/>J Inherit Metab Dis
          <year>2016</year>
<volume>39</volume>
<issue>Supplement 1</issue>
<fpage>313</fpage>
</element-citation>
</ref>
<ref id="CR135">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martens</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Rake</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ullrich</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Weinstein</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Merkel</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pregnancies in glycogen storage disease type Ia</article-title>
<source/>Am J Obstet Gynecol
          <year>2008</year>
<volume>198</volume>
<issue>6</issue>
<fpage>646.e1</fpage>
<lpage>646.e7</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajog.2007.11.050</pub-id>
<pub-id pub-id-type="pmid">18241814</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dagli</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Correia</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bhattacharya</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Steinkrauss</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pregnancy in glycogen storage disease type Ib: Gestational care and report of first successful deliveries</article-title>
<source/>J Inherit Metab Dis
          <year>2010</year>
<volume>33</volume>
<issue>Suppl 3</issue>
<fpage>S151</fpage>
<lpage>S157</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-010-9054-1</pub-id>
<pub-id pub-id-type="pmid">20386986</pub-id>
</element-citation>
</ref>
<ref id="CR137">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Muiesan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Heaton</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Successful pregnancy after combined renal-hepatic transplantation in glycogen storage disease type Ia</article-title>
<source/>J Inherit Metab Dis
          <year>2004</year>
<volume>27</volume>
<issue>4</issue>
<fpage>537</fpage>
<lpage>538</lpage>
<pub-id pub-id-type="doi">10.1023/B:BOLI.0000037397.39725.57</pub-id>
<pub-id pub-id-type="pmid">15334735</pub-id>
</element-citation>
</ref>
<ref id="CR138">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sechi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Deroma</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lapolla</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Paci</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Melis</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Burlina</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study</article-title>
<source/>J Inherit Metab Dis
          <year>2013</year>
<volume>36</volume>
<issue>1</issue>
<fpage>83</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-012-9490-1</pub-id>
<pub-id pub-id-type="pmid">22562700</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrecchia</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Guenette</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Potocik</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Weinstein</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Pregnancy in women with glycogen storage disease Ia and Ib</article-title>
<source/>J Perinat Neonatal Nurs
          <year>2014</year>
<volume>28</volume>
<issue>1</issue>
<fpage>26</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1097/JPN.0000000000000017</pub-id>
<pub-id pub-id-type="pmid">24476649</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryan</surname>
<given-names>IP</given-names>
</name>
<name>
<surname>Havel</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Laros</surname>
<given-names>RK</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Three consecutive pregnancies in a patient with glycogen storage disease type IA (von Gierke's disease)</article-title>
<source/>Am J Obstet Gynecol
          <year>1994</year>
<volume>170</volume>
<issue>6</issue>
<fpage>1687</fpage>
<lpage>1690</lpage>
<pub-id pub-id-type="doi">10.1016/S0002-9378(94)70342-6</pub-id>
<pub-id pub-id-type="pmid">8203427</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Obayashi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Suzumori</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glycogen storage disease type Ia (GSD Ia) during pregnancy: Report of a case complicated by fetal growth restriction and preeclampsia</article-title>
<source/>J Obstet Gynaecol Res
          <year>2010</year>
<volume>36</volume>
<issue>5</issue>
<fpage>1125</fpage>
<lpage>1129</lpage>
<pub-id pub-id-type="doi">10.1111/j.1447-0756.2010.01287.x</pub-id>
<pub-id pub-id-type="pmid">21058447</pub-id>
</element-citation>
</ref>
<ref id="CR142">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramachandran</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wedatilake</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Coats</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>PJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pregnancy and its management in women with GSD type III - a single Centre experience</article-title>
<source/>J Inherit Metab Dis
          <year>2012</year>
<volume>35</volume>
<issue>2</issue>
<fpage>245</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-011-9384-7</pub-id>
<pub-id pub-id-type="pmid">21947574</pub-id>
</element-citation>
</ref>
<ref id="CR143">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cochrane</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Alderman</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Normal pregnancy and successful delivery in myophosphorylase deficiency (McArdle's disease)</article-title>
<source/>J Neurol Neurosurg Psychiatry
          <year>1973</year>
<volume>36</volume>
<issue>2</issue>
<fpage>225</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.36.2.225</pub-id>
<pub-id pub-id-type="pmid">4513545</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lepoivre</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Legendre</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pinaud</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Anesthesia for cesarean section in a patient with McArdle disease and hereditary dilated cardiomyopathy</article-title>
<source/>Ann Fr Anesth Reanim
          <year>2002</year>
<volume>21</volume>
<issue>6</issue>
<fpage>517</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1016/S0750-7658(02)00645-7</pub-id>
<pub-id pub-id-type="pmid">12134596</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coleman</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>McArdle's disease. Problems of anaesthetic management for caesarean section</article-title>
<source/>Anaesthesia
          <year>1984</year>
<volume>39</volume>
<issue>8</issue>
<fpage>784</fpage>
<lpage>787</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2044.1984.tb06524.x</pub-id>
<pub-id pub-id-type="pmid">6591841</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samuels</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Coleman</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>McArdle's disease and caesarean section</article-title>
<source/>Anaesthesia
          <year>1988</year>
<volume>43</volume>
<issue>2</issue>
<fpage>161</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2044.1988.tb05503.x</pub-id>
<pub-id pub-id-type="pmid">3162658</pub-id>
</element-citation>
</ref>
<ref id="CR147">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Findlay</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rijhsinghani</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Acute compartment syndrome: Clinical course and laboratory findings in pregnant patients with McArdle's disease</article-title>
<source/>Pain Med
          <year>2014</year>
<volume>15</volume>
<issue>3</issue>
<fpage>481</fpage>
<lpage>482</lpage>
<pub-id pub-id-type="doi">10.1111/pme.12279</pub-id>
<pub-id pub-id-type="pmid">24224978</pub-id>
</element-citation>
</ref>
<ref id="CR148">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thakur</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Puscheck</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Primary ovarian insufficiency in classic galactosemia: Current understanding and future research opportunities</article-title>
<source/>J Assist Reprod Genet
          <year>2018</year>
<volume>35</volume>
<issue>1</issue>
<fpage>3</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1007/s10815-017-1039-7</pub-id>
<pub-id pub-id-type="pmid">28932969</pub-id>
</element-citation>
</ref>
<ref id="CR149">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coelho</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Rubio-Gozalbo</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Vicente</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Sweet and sour: An update on classic galactosemia</article-title>
<source/>J Inherit Metab Dis
          <year>2017</year>
<volume>40</volume>
<issue>3</issue>
<fpage>325</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-017-0029-3</pub-id>
<pub-id pub-id-type="pmid">28281081</pub-id>
</element-citation>
</ref>
<ref id="CR150">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Erven</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Cassiman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Connolly</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Forga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gautschi</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fertility in adult women with classic galactosemia and primary ovarian insufficiency</article-title>
<source/>Fertil Steril
          <year>2017</year>
<volume>108</volume>
<issue>1</issue>
<fpage>168</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2017.05.013</pub-id>
<pub-id pub-id-type="pmid">28579413</pub-id>
</element-citation>
</ref>
<ref id="CR151">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gubbels</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Wodzig</surname>
<given-names>WK</given-names>
</name>
<name>
<surname>Olthaar</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Jaeken</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sweep</surname>
<given-names>FC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FSH isoform pattern in classic galactosemia</article-title>
<source/>J Inherit Metab Dis
          <year>2011</year>
<volume>34</volume>
<issue>2</issue>
<fpage>387</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-010-9180-9</pub-id>
<pub-id pub-id-type="pmid">20814826</pub-id>
</element-citation>
</ref>
<ref id="CR152">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gubbels</surname>
<given-names>Cynthia S.</given-names>
</name>
<name>
<surname>Kuppens</surname>
<given-names>Simone M.I.</given-names>
</name>
<name>
<surname>Bakker</surname>
<given-names>Jaap A.</given-names>
</name>
<name>
<surname>Konings</surname>
<given-names>Constantijn J.A.M.</given-names>
</name>
<name>
<surname>Wodzig</surname>
<given-names>K. Will</given-names>
</name>
<name>
<surname>de Sain–van der Velden</surname>
<given-names>Monique G.M.</given-names>
</name>
<name>
<surname>Menheere</surname>
<given-names>Paul P.</given-names>
</name>
<name>
<surname>Rubio-Gozalbo</surname>
<given-names>M. Estela</given-names>
</name>
</person-group>
<article-title>Pregnancy in classic galactosemia despite undetectable anti-Müllerian hormone</article-title>
<source/>Fertility and Sterility
          <year>2009</year>
<volume>91</volume>
<issue>4</issue>
<fpage>1293.e13-1293.e16</fpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2008.12.031</pub-id>
</element-citation>
</ref>
<ref id="CR153">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gubbels</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Land</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Rubio-Gozalbo</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Fertility and impact of pregnancies on the mother and child in classic galactosemia</article-title>
<source/>Obstet Gynecol Surv
          <year>2008</year>
<volume>63</volume>
<issue>5</issue>
<fpage>334</fpage>
<lpage>343</lpage>
<pub-id pub-id-type="doi">10.1097/OGX.0b013e31816ff6c5</pub-id>
<pub-id pub-id-type="pmid">18419833</pub-id>
</element-citation>
</ref>
<ref id="CR154">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quintana</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sturiale</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Montero</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Andrade</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Couce</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Secondary disorders of glycosylation in inborn errors of fructose metabolism</article-title>
<source/>J Inherit Metab Dis
          <year>2009</year>
<volume>32</volume>
<issue>Suppl 1</issue>
<fpage>S273</fpage>
<lpage>S278</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-009-1219-4</pub-id>
<pub-id pub-id-type="pmid">19768653</pub-id>
</element-citation>
</ref>
<ref id="CR155">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marks</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ordorica</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hoskins</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>BK</given-names>
</name>
</person-group>
<article-title>Congenital hereditary fructose intolerance and pregnancy</article-title>
<source/>Am J Obstet Gynecol
          <year>1989</year>
<volume>160</volume>
<issue>2</issue>
<fpage>362</fpage>
<lpage>363</lpage>
<pub-id pub-id-type="doi">10.1016/0002-9378(89)90445-6</pub-id>
<pub-id pub-id-type="pmid">2916618</pub-id>
</element-citation>
</ref>
<ref id="CR156">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krishnamurthy</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Eschrich</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Boney</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kishnani</surname>
<given-names>PS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Three successful pregnancies through dietary management of fructose-1,6-bisphosphatase deficiency</article-title>
<source/>J Inherit Metab Dis
          <year>2007</year>
<volume>30</volume>
<issue>5</issue>
<fpage>819</fpage>
<pub-id pub-id-type="doi">10.1007/s10545-007-0606-y</pub-id>
<pub-id pub-id-type="pmid">17705024</pub-id>
</element-citation>
</ref>
<ref id="CR157">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vantyghem</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Dobbelaere</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mention</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wemeau</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Saudubray</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Douillard</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Endocrine manifestations related to inherited metabolic diseases in adults</article-title>
<source/>Orphanet J Rare Dis
          <year>2012</year>
<volume>7</volume>
<fpage>11</fpage>
<pub-id pub-id-type="doi">10.1186/1750-1172-7-11</pub-id>
<pub-id pub-id-type="pmid">22284844</pub-id>
</element-citation>
</ref>
<ref id="CR158">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wurm</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Loffler</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lindinger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gortner</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Congenital disorders of glycosylation type Ia as a cause of mirror syndrome</article-title>
<source/>J Perinatol
          <year>2007</year>
<volume>27</volume>
<issue>12</issue>
<fpage>802</fpage>
<lpage>804</lpage>
<pub-id pub-id-type="doi">10.1038/sj.jp.7211847</pub-id>
<pub-id pub-id-type="pmid">18034167</pub-id>
</element-citation>
</ref>
<ref id="CR159">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellingson</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Wick</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>White</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Saenger</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Pichurin</surname>
<given-names>PN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pregnancy in an individual with mild smith-Lemli-Opitz syndrome</article-title>
<source/>Clin Genet
          <year>2014</year>
<volume>85</volume>
<issue>5</issue>
<fpage>495</fpage>
<lpage>497</lpage>
<pub-id pub-id-type="doi">10.1111/cge.12209</pub-id>
<pub-id pub-id-type="pmid">23790112</pub-id>
</element-citation>
</ref>
<ref id="CR160">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaudet</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>MacKenzie</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>GN</given-names>
</name>
</person-group>
<article-title>Fat-soluble vitamin deficiency in pregnancy: A case report and review of abetalipoproteinemia</article-title>
<source/>J Obstet Gynaecol Can
          <year>2006</year>
<volume>28</volume>
<issue>8</issue>
<fpage>716</fpage>
<lpage>719</lpage>
<pub-id pub-id-type="doi">10.1016/S1701-2163(16)32235-6</pub-id>
<pub-id pub-id-type="pmid">17022912</pub-id>
</element-citation>
</ref>
<ref id="CR161">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmer</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Knudtson</surname>
<given-names>EJ</given-names>
</name>
</person-group>
<article-title>Abetalipoproteinemia complicating the puerperium</article-title>
<source/>Obstet Gynecol
          <year>2008</year>
<volume>111</volume>
<issue>2 Pt 2</issue>
<fpage>575</fpage>
<lpage>577</lpage>
<pub-id pub-id-type="doi">10.1097/01.AOG.0000295869.92443.ce</pub-id>
<pub-id pub-id-type="pmid">18239027</pub-id>
</element-citation>
</ref>
<ref id="CR162">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seckeler</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Linden</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Maternal abetalipoproteinemia resulting in multiple fetal anomalies</article-title>
<source/>Neonatology
          <year>2008</year>
<volume>94</volume>
<issue>4</issue>
<fpage>310</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="doi">10.1159/000151653</pub-id>
<pub-id pub-id-type="pmid">18784430</pub-id>
</element-citation>
</ref>
<ref id="CR163">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Matts</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>A successful spontaneous pregnancy in abetalipoproteinemia: Amsterdam or the art of vitamin replacement?</article-title>
<source/>Case Reports
          <year>2014</year>
<volume>2014</volume>
<issue>dec08 1</issue>
<fpage>bcr2014206754</fpage>
<lpage>bcr2014206754</lpage>
</element-citation>
</ref>
<ref id="CR164">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukao</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sass</surname>
<given-names>JO</given-names>
</name>
<name>
<surname>Hori</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Orii</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Aoyama</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Ketone body metabolism and its defects</article-title>
<source/>J Inherit Metab Dis
          <year>2014</year>
<volume>37</volume>
<issue>4</issue>
<fpage>541</fpage>
<lpage>551</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-014-9704-9</pub-id>
<pub-id pub-id-type="pmid">24706027</pub-id>
</element-citation>
</ref>
<ref id="CR165">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santosa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Donner</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Vom Dahl</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fleisch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hoehn</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mayatepek</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Favourable outcome in two pregnancies in a patient with 3-Hydroxy-3-Methylglutaryl-CoA Lyase deficiency</article-title>
<source/>JIMD Rep
          <year>2017</year>
<volume>37</volume>
<fpage>1</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1007/8904_2017_7</pub-id>
<pub-id pub-id-type="pmid">28220407</pub-id>
</element-citation>
</ref>
<ref id="CR166">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kayani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Botros</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Beta-ketothiolase deficiency and pregnancy</article-title>
<source/>Int J Obstet Anesth
          <year>2013</year>
<volume>22</volume>
<issue>3</issue>
<fpage>260</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijoa.2013.03.006</pub-id>
<pub-id pub-id-type="pmid">23664791</pub-id>
</element-citation>
</ref>
<ref id="CR167">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sims</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Brackett</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Treem</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Hale</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>1995</year>
<volume>92</volume>
<issue>3</issue>
<fpage>841</fpage>
<lpage>845</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.92.3.841</pub-id>
<pub-id pub-id-type="pmid">7846063</pub-id>
</element-citation>
</ref>
<ref id="CR168">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Natarajan</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Thangaraj</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Eapen</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Ramachandran</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mukhopadhya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mathai</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Liver injury in acute fatty liver of pregnancy: Possible link to placental mitochondrial dysfunction and oxidative stress</article-title>
<source/>Hepatology
          <year>2010</year>
<volume>51</volume>
<issue>1</issue>
<fpage>191</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1002/hep.23245</pub-id>
<pub-id pub-id-type="pmid">20034024</pub-id>
</element-citation>
</ref>
<ref id="CR169">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moreea</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Lippiatt</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Acute liver failure in pregnancy associated with maternal MCAD deficiency</article-title>
<source/>J Inherit Metab Dis
          <year>2007</year>
<volume>30</volume>
<issue>1</issue>
<fpage>103</fpage>
<pub-id pub-id-type="doi">10.1007/s10545-006-0520-8</pub-id>
<pub-id pub-id-type="pmid">17186412</pub-id>
</element-citation>
</ref>
<ref id="CR170">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Innes</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Seargeant</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Balachandra</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Roe</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Wanders</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Ruiter</surname>
<given-names>JP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy</article-title>
<source/>Pediatr Res
          <year>2000</year>
<volume>47</volume>
<issue>1</issue>
<fpage>43</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1203/00006450-200001000-00010</pub-id>
<pub-id pub-id-type="pmid">10625081</pub-id>
</element-citation>
</ref>
<ref id="CR171">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Maldegem</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Wanders</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Wijburg</surname>
<given-names>FA</given-names>
</name>
</person-group>
<article-title>Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency</article-title>
<source/>J Inherit Metab Dis
          <year>2010</year>
<volume>33</volume>
<issue>5</issue>
<fpage>507</fpage>
<lpage>511</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-010-9080-z</pub-id>
<pub-id pub-id-type="pmid">20429031</pub-id>
</element-citation>
</ref>
<ref id="CR172">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The HELLP syndrome associated wiht fetal medium-chain acyl-CoA dehydrogenase deficiency</article-title>
<source/>J Inherit Metab Dis
          <year>2000</year>
<volume>23</volume>
<issue>5</issue>
<fpage>518</fpage>
<lpage>519</lpage>
<pub-id pub-id-type="doi">10.1023/A:1005676600975</pub-id>
<pub-id pub-id-type="pmid">10947209</pub-id>
</element-citation>
</ref>
<ref id="CR173">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ylitalo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Vanttinen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Halmesmaki</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tyni</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Serious pregnancy complications in a patient with previously undiagnosed carnitine palmitoyltransferase 1 deficiency</article-title>
<source/>Am J Obstet Gynecol
          <year>2005</year>
<volume>192</volume>
<issue>6</issue>
<fpage>2060</fpage>
<lpage>2062</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajog.2004.11.005</pub-id>
<pub-id pub-id-type="pmid">15970898</pub-id>
</element-citation>
</ref>
<ref id="CR174">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryckman</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Shchelochkov</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Berberich</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Copeland</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dagle</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The influence of maternal disease on metabolites measured as part of newborn screening</article-title>
<source/>J Matern Fetal Neonatal Med
          <year>2013</year>
<volume>26</volume>
<issue>14</issue>
<fpage>1380</fpage>
<lpage>1383</lpage>
<pub-id pub-id-type="doi">10.3109/14767058.2013.791267</pub-id>
<pub-id pub-id-type="pmid">23550828</pub-id>
</element-citation>
</ref>
<ref id="CR175">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morton</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Presumed acute fatty liver of pregnancy following influenza A hepatitis</article-title>
<source/>Obstet Med
          <year>2017</year>
<volume>10</volume>
<issue>4</issue>
<fpage>186</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1177/1753495X17695173</pub-id>
<pub-id pub-id-type="pmid">29225680</pub-id>
</element-citation>
</ref>
<ref id="CR176">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarasenko</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>LN</given-names>
</name>
<name>
<surname>Chatterji-Len</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zerfas</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Cusmano-Ozog</surname>
<given-names>K</given-names>
</name>
<name>
<surname>McGuire</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>Kupffer cells modulate hepatic fatty acid oxidation during infection with PR8 influenza</article-title>
<source/>Biochim Biophys Acta
          <year>2015</year>
<volume>1852</volume>
<issue>11</issue>
<fpage>2391</fpage>
<lpage>2401</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2015.08.021</pub-id>
<pub-id pub-id-type="pmid">26319418</pub-id>
</element-citation>
</ref>
<ref id="CR177">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moren</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hernandez</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guitart-Mampel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Garrabou</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Mitochondrial toxicity in human pregnancy: An update on clinical and experimental approaches in the last 10 years</article-title>
<source/>Int J Environ Res Public Health
          <year>2014</year>
<volume>11</volume>
<issue>9</issue>
<fpage>9897</fpage>
<lpage>9918</lpage>
<pub-id pub-id-type="doi">10.3390/ijerph110909897</pub-id>
<pub-id pub-id-type="pmid">25247430</pub-id>
</element-citation>
</ref>
<ref id="CR178">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Illsinger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Janzen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sander</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Bednarczyk</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mallunat</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Preeclampsia and HELLP syndrome: Impaired mitochondrial function in umbilical endothelial cells</article-title>
<source/>Reprod Sci
          <year>2010</year>
<volume>17</volume>
<issue>3</issue>
<fpage>219</fpage>
<lpage>226</lpage>
<pub-id pub-id-type="doi">10.1177/1933719109351597</pub-id>
<pub-id pub-id-type="pmid">20065299</pub-id>
</element-citation>
</ref>
<ref id="CR179">
<label>179.</label>
<mixed-citation publication-type="other">Sinha RA, Singh BK, Yen PM. Direct effects of thyroid hormones on hepatic lipid metabolism. Nat rev Endocrinol. 2018.</mixed-citation>
</ref>
<ref id="CR180">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Laat</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fleuren</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Bekker</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Smeitink</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Obstsetric complications in carriers of the m.3243A&gt;G mutation, a retrospective cohort study on maternal and fetal outcome</article-title>
<source/>Mitochondrion
          <year>2015</year>
<volume>25</volume>
<fpage>98</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1016/j.mito.2015.10.005</pub-id>
<pub-id pub-id-type="pmid">26455484</pub-id>
</element-citation>
</ref>
<ref id="CR181">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Eerd</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Brusse</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Adriaens</surname>
<given-names>VF</given-names>
</name>
<name>
<surname>Mankowski</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Praet</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Michels</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Management of an LCHADD patient during pregnancy and high intensity exercise</article-title>
<source/>JIMD Rep
          <year>2017</year>
<volume>32</volume>
<fpage>95</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="doi">10.1007/8904_2016_561</pub-id>
<pub-id pub-id-type="pmid">27334895</pub-id>
</element-citation>
</ref>
<ref id="CR182">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mendez-Figueroa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shchelochkov</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Shaibani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Aagaard-Tillery</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shinawi</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Clinical and biochemical improvement of very long-chain acyl-CoA dehydrogenase deficiency in pregnancy</article-title>
<source/>J Perinatol
          <year>2010</year>
<volume>30</volume>
<issue>8</issue>
<fpage>558</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="doi">10.1038/jp.2009.198</pub-id>
<pub-id pub-id-type="pmid">20668464</pub-id>
</element-citation>
</ref>
<ref id="CR183">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magoulas</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>El-Hattab</surname>
<given-names>AW</given-names>
</name>
</person-group>
<article-title>Systemic primary carnitine deficiency: An overview of clinical manifestations, diagnosis, and management</article-title>
<source/>Orphanet J Rare Dis
          <year>2012</year>
<volume>7</volume>
<fpage>68</fpage>
<pub-id pub-id-type="doi">10.1186/1750-1172-7-68</pub-id>
<pub-id pub-id-type="pmid">22989098</pub-id>
</element-citation>
</ref>
<ref id="CR184">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yanagawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sakaguchi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakao</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sanke</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with deterioration during pregnancy</article-title>
<source/>Intern Med
          <year>1998</year>
<volume>37</volume>
<issue>9</issue>
<fpage>780</fpage>
<lpage>783</lpage>
<pub-id pub-id-type="doi">10.2169/internalmedicine.37.780</pub-id>
<pub-id pub-id-type="pmid">9804089</pub-id>
</element-citation>
</ref>
<ref id="CR185">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sikdar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sahni</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Miglani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Daga</surname>
<given-names>MK</given-names>
</name>
</person-group>
<article-title>Pregnancy-precipitated status epilepticus: A rare presentation of MELAS syndrome</article-title>
<source/>Neurol India
          <year>2007</year>
<volume>55</volume>
<issue>1</issue>
<fpage>82</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.4103/0028-3886.30440</pub-id>
<pub-id pub-id-type="pmid">17272912</pub-id>
</element-citation>
</ref>
<ref id="CR186">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sánchez</surname>
<given-names>Miriam V.</given-names>
</name>
<name>
<surname>Romero</surname>
<given-names>Rafael</given-names>
</name>
</person-group>
<article-title>Acute Pulmonary Edema Secondary to Pregnancy in a Patient With the Mitochondrial Disease MELAS</article-title>
<source/>Revista Española de Cardiología (English Edition)
          <year>2010</year>
<volume>63</volume>
<issue>5</issue>
<fpage>615</fpage>
<lpage>617</lpage>
<pub-id pub-id-type="doi">10.1016/S1885-5857(10)70127-4</pub-id>
</element-citation>
</ref>
<ref id="CR187">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finsterer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zarrouk-Mahjoub</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Pre-eclampsia in a parturient with MELAS</article-title>
<source/>A A Pract
          <year>2018</year>
<volume>10</volume>
<issue>1</issue>
<fpage>31</fpage>
<pub-id pub-id-type="doi">10.1213/XAA.0000000000000618</pub-id>
<pub-id pub-id-type="pmid">29293489</pub-id>
</element-citation>
</ref>
<ref id="CR188">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bell</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Higgie</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Joshi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rucker</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Farzi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Siddiqui</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Anesthetic Management of Mitochondrial Encephalopathy with Lactic Acidosis and Stroke-like Episodes (MELAS syndrome) in a high-risk pregnancy: A case report</article-title>
<source/>A A Case Rep
          <year>2017</year>
<volume>9</volume>
<issue>2</issue>
<fpage>38</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1213/XAA.0000000000000520</pub-id>
<pub-id pub-id-type="pmid">28398928</pub-id>
</element-citation>
</ref>
<ref id="CR189">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moriarty</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>McFarland</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Whittaker</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Burch</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Turnbull</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>RW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pre-eclampsia and magnesium toxicity with therapeutic plasma level in a woman with m.3243A&gt;G melas mutation</article-title>
<source/>J Obstet Gynaecol
          <year>2008</year>
<volume>28</volume>
<issue>3</issue>
<fpage>349</fpage>
<pub-id pub-id-type="doi">10.1080/01443610802048545</pub-id>
<pub-id pub-id-type="pmid">18569490</pub-id>
</element-citation>
</ref>
<ref id="CR190">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Annaiah</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Kodakkattil</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sriemevan</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Pregnancy with mitochondrial encephalopathy lactic acidosis and stroke-like episodes (MELAS syndrome) leading to confusion in the diagnosis of pulmonary embolism</article-title>
<source/>J Obstet Gynaecol
          <year>2007</year>
<volume>27</volume>
<issue>6</issue>
<fpage>618</fpage>
<lpage>619</lpage>
<pub-id pub-id-type="doi">10.1080/01443610701546318</pub-id>
<pub-id pub-id-type="pmid">17896266</pub-id>
</element-citation>
</ref>
<ref id="CR191">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stepien</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Wierzbicki</surname>
<given-names>AS</given-names>
</name>
</person-group>
<article-title>Poll-the BT, Waterham HR, Hendriksz CJ. The challenges of a successful pregnancy in a patient with adult Refsum's disease due to Phytanoyl-CoA hydroxylase deficiency</article-title>
<source/>JIMD Rep
          <year>2017</year>
<volume>33</volume>
<fpage>49</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1007/8904_2016_569</pub-id>
<pub-id pub-id-type="pmid">27518778</pub-id>
</element-citation>
</ref>
<ref id="CR192">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Nicholls</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shankar</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Sunder-Plassmann</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Koeller</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nedd</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study</article-title>
<source/>J Med Genet
          <year>2017</year>
<volume>54</volume>
<issue>4</issue>
<fpage>288</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="doi">10.1136/jmedgenet-2016-104178</pub-id>
<pub-id pub-id-type="pmid">27834756</pub-id>
</element-citation>
</ref>
<ref id="CR193">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenbaum</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Management of women with Gaucher disease in the reproductive age</article-title>
<source/>Thromb Res
          <year>2015</year>
<volume>135</volume>
<issue>Suppl 1</issue>
<fpage>S49</fpage>
<lpage>S51</lpage>
<pub-id pub-id-type="doi">10.1016/S0049-3848(15)50443-X</pub-id>
<pub-id pub-id-type="pmid">25903536</pub-id>
</element-citation>
</ref>
<ref id="CR194">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Granovsky-Grisaru</surname>
<given-names>Sorina</given-names>
</name>
<name>
<surname>Belmatoug</surname>
<given-names>Nadia</given-names>
</name>
<name>
<surname>vom Dahl</surname>
<given-names>Stephan</given-names>
</name>
<name>
<surname>Mengel</surname>
<given-names>Eugen</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>Elizabeth</given-names>
</name>
<name>
<surname>Zimran</surname>
<given-names>Ari</given-names>
</name>
</person-group>
<article-title>The management of pregnancy in Gaucher disease</article-title>
<source/>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology
          <year>2011</year>
<volume>156</volume>
<issue>1</issue>
<fpage>3</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejogrb.2010.12.024</pub-id>
<pub-id pub-id-type="pmid">21269752</pub-id>
</element-citation>
</ref>
<ref id="CR195">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwafuchi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Maruyama</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Morioka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Oyama</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enzyme replacement therapy in a patient of heterozygous Fabry disease: Clinical and pathological evaluations by repeat kidney biopsy and a successful pregnancy</article-title>
<source/>CEN Case Rep
          <year>2017</year>
<volume>6</volume>
<issue>2</issue>
<fpage>210</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1007/s13730-017-0277-y</pub-id>
<pub-id pub-id-type="pmid">29019163</pub-id>
</element-citation>
</ref>
<ref id="CR196">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Ploeg</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Kruijshaar</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Toscano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Laforet</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Angelini</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lachmann</surname>
<given-names>RH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: A 10-year experience</article-title>
<source/>Eur J Neurol
          <year>2017</year>
<volume>24</volume>
<issue>6</issue>
<fpage>768</fpage>
<lpage>e31</lpage>
<pub-id pub-id-type="doi">10.1111/ene.13285</pub-id>
<pub-id pub-id-type="pmid">28477382</pub-id>
</element-citation>
</ref>
<ref id="CR197">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>Alison</given-names>
</name>
<name>
<surname>Brandon</surname>
<given-names>Rebecca</given-names>
</name>
<name>
<surname>Cavell</surname>
<given-names>Debbie</given-names>
</name>
<name>
<surname>murphy</surname>
<given-names>Elaine</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>Fiona</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>Sophie</given-names>
</name>
<name>
<surname>Talaulikar</surname>
<given-names>Vikram</given-names>
</name>
<name>
<surname>Wilcox</surname>
<given-names>Gisela</given-names>
</name>
</person-group>
<article-title>The experiences and information requirements of women with a mucopolysaccharide (MPS) or related condition during pregnancy, birth and the postnatal period</article-title>
<source/>Molecular Genetics and Metabolism
          <year>2016</year>
<volume>117</volume>
<issue>2</issue>
<fpage>S121</fpage>
<pub-id pub-id-type="doi">10.1016/j.ymgme.2015.12.488</pub-id>
</element-citation>
</ref>
<ref id="CR198">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castorina</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Antuzzi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Successful pregnancy and breastfeeding in a woman with mucopolysaccharidosis type I while receiving laronidase enzyme replacement</article-title>
<source/>Ther Clin Exp Obstet Gynecol
          <year>2015</year>
<volume>42</volume>
<issue>1</issue>
<fpage>108</fpage>
<lpage>113</lpage>
</element-citation>
</ref>
<ref id="CR199">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Troko</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Poonawala</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Geberhiwot</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Multidisciplinary team approach is key for managing pregnancy and delivery in patient with rare, complex MPS I</article-title>
<source/>JIMD Rep
          <year>2016</year>
<volume>30</volume>
<fpage>1</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1007/8904_2016_527</pub-id>
<pub-id pub-id-type="pmid">26920904</pub-id>
</element-citation>
</ref>
<ref id="CR200">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holbeck-Brendel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Poulsen</surname>
<given-names>BK</given-names>
</name>
</person-group>
<article-title>Treatment with enzyme replacement therapy during pregnancy in a patient with Pompe disease</article-title>
<source/>Neuromuscul Disord
          <year>2017</year>
<volume>27</volume>
<issue>10</issue>
<fpage>956</fpage>
<lpage>958</lpage>
<pub-id pub-id-type="doi">10.1016/j.nmd.2017.06.556</pub-id>
<pub-id pub-id-type="pmid">28735900</pub-id>
</element-citation>
</ref>
<ref id="CR201">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karabul</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Berndt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kornblum</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kley</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Wenninger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tiling</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pregnancy and delivery in women with Pompe disease</article-title>
<source/>Mol Genet Metab
          <year>2014</year>
<volume>112</volume>
<issue>2</issue>
<fpage>148</fpage>
<lpage>153</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymgme.2014.03.010</pub-id>
<pub-id pub-id-type="pmid">24726296</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>